<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/91363DD3-3DEA-4D93-93B7-7A44176DADCE"><gtr:id>91363DD3-3DEA-4D93-93B7-7A44176DADCE</gtr:id><gtr:name>Catholic University of Louvain</gtr:name><gtr:address><gtr:line1>3 Place L Pasteur</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/598EC0B6-AEB9-4323-95F7-5B4EFCDDF33E"><gtr:id>598EC0B6-AEB9-4323-95F7-5B4EFCDDF33E</gtr:id><gtr:name>Friedrich-Alexander University</gtr:name><gtr:address><gtr:line1>Schlossplatz 4</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6711BFCB-ACD5-4149-9C97-283269DF2778"><gtr:id>6711BFCB-ACD5-4149-9C97-283269DF2778</gtr:id><gtr:name>Mayo Clinic</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9218106A-E8CE-46A5-AABC-B4C8ED148690"><gtr:id>9218106A-E8CE-46A5-AABC-B4C8ED148690</gtr:id><gtr:name>University of Amsterdam</gtr:name><gtr:address><gtr:line1>Liaison Office</gtr:line1><gtr:line2>PO Box 19268</gtr:line2><gtr:line4>Amsterdam</gtr:line4><gtr:line5>Amsterdam</gtr:line5><gtr:postCode>1000 GG</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/395F850A-031E-45AD-817A-4C46D042B92C"><gtr:id>395F850A-031E-45AD-817A-4C46D042B92C</gtr:id><gtr:name>University of Cincinnati</gtr:name><gtr:address><gtr:line1>University of Cincinnati</gtr:line1><gtr:line2>2624 Clifton Avenue</gtr:line2><gtr:postCode>OH 45221-0</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E6DF5D67-D7D6-4891-9B77-959BE9D17DAC"><gtr:id>E6DF5D67-D7D6-4891-9B77-959BE9D17DAC</gtr:id><gtr:name>The Walter and Eliza Hall Institute of Medical Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D3EB34F1-7CAE-41B1-A951-98FA4BE48D2E"><gtr:id>D3EB34F1-7CAE-41B1-A951-98FA4BE48D2E</gtr:id><gtr:name>Janssen Biotech, Inc.</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/80DD41C8-30F5-4AB5-A2F4-F3285B212F89"><gtr:id>80DD41C8-30F5-4AB5-A2F4-F3285B212F89</gtr:id><gtr:name>Johns Hopkins Medicine</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/430A04B6-0F63-43BA-B78B-8DD4147CAF43"><gtr:id>430A04B6-0F63-43BA-B78B-8DD4147CAF43</gtr:id><gtr:name>University of Paris South 11</gtr:name><gtr:address><gtr:line1>Batiment 300</gtr:line1><gtr:line4>Orsay cedex</gtr:line4><gtr:line5>F-91405</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/103D3F37-4066-444D-93DA-A10CF99F10F5"><gtr:id>103D3F37-4066-444D-93DA-A10CF99F10F5</gtr:id><gtr:name>Austrian Academy of Sciences</gtr:name><gtr:address><gtr:line1>Lazarettgasse 14</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E913F6AA-9FFC-4300-83DB-799EC8F3A4E7"><gtr:id>E913F6AA-9FFC-4300-83DB-799EC8F3A4E7</gtr:id><gtr:name>University of Maryland</gtr:name><gtr:address><gtr:line1>University of Maryland</gtr:line1><gtr:postCode>20742</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A06FED91-B1C2-4601-A8BC-7FDF7DF5EF3D"><gtr:id>A06FED91-B1C2-4601-A8BC-7FDF7DF5EF3D</gtr:id><gtr:name>University Libre Bruxelles (Universit? Libre de Bruxelles ULB)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/744EC7A2-0524-4F61-99B4-D4AEB6AE9854"><gtr:id>744EC7A2-0524-4F61-99B4-D4AEB6AE9854</gtr:id><gtr:name>Institute for Research on Health in the Working Environment (IRSET)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/416F403A-33BF-45CD-9639-25A0A29DB1E9"><gtr:id>416F403A-33BF-45CD-9639-25A0A29DB1E9</gtr:id><gtr:name>Gifu Pharmaceutical University</gtr:name><gtr:address><gtr:line1>5-6-1 Mitahora-Higashi</gtr:line1><gtr:postCode>502-8585</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B16D710A-5C40-44CA-A796-B37EC8935E99"><gtr:id>B16D710A-5C40-44CA-A796-B37EC8935E99</gtr:id><gtr:name>University of Michigan</gtr:name><gtr:address><gtr:line1>3003 S. State Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/13C67365-0236-4CCD-AF52-209DC562C679"><gtr:id>13C67365-0236-4CCD-AF52-209DC562C679</gtr:id><gtr:name>Research Institute for Diseases of the Chest Kyushi</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/064A41A2-AC2E-4ACC-A55B-D38D3434BD6A"><gtr:id>064A41A2-AC2E-4ACC-A55B-D38D3434BD6A</gtr:id><gtr:name>Queen's Medical Centre</gtr:name><gtr:address><gtr:line1>Queen's Medical Centre</gtr:line1><gtr:line2>Derby Rd</gtr:line2><gtr:postCode>NG7 2UH</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7B9C2D48-4CEC-46B1-89E7-DE5DCD1FA320"><gtr:id>7B9C2D48-4CEC-46B1-89E7-DE5DCD1FA320</gtr:id><gtr:name>Borstel Research Centre</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/58930F3F-9B16-4DC2-833F-C72033E77A1E"><gtr:id>58930F3F-9B16-4DC2-833F-C72033E77A1E</gtr:id><gtr:name>Boston Children's Hospital</gtr:name><gtr:address><gtr:line1>Boston Childrens Hospital</gtr:line1><gtr:line2>Karp Building</gtr:line2><gtr:line3>9th floor, Rm 09210 1 Blackfan Circle</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2E8E7A84-3BC7-4739-986D-C05FC31789B8"><gtr:id>2E8E7A84-3BC7-4739-986D-C05FC31789B8</gtr:id><gtr:name>Charit? - University of Medicine Berlin</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F77EAB28-C13B-419F-AC60-BA61966B71DE"><gtr:id>F77EAB28-C13B-419F-AC60-BA61966B71DE</gtr:id><gtr:name>University of Leipzig</gtr:name><gtr:address><gtr:line1>Ritterstrasse 26, D-04109 Leipzig</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9A22541F-DA58-481E-8D0C-C4BCF4EA030E"><gtr:id>9A22541F-DA58-481E-8D0C-C4BCF4EA030E</gtr:id><gtr:name>EMBL - European Bioinformatics Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB10 1SD</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/93B13D3A-863C-46E8-A4C7-1EE4759A7E9B"><gtr:id>93B13D3A-863C-46E8-A4C7-1EE4759A7E9B</gtr:id><gtr:name>Cleveland Clinic</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/91363DD3-3DEA-4D93-93B7-7A44176DADCE"><gtr:id>91363DD3-3DEA-4D93-93B7-7A44176DADCE</gtr:id><gtr:name>Catholic University of Louvain</gtr:name><gtr:address><gtr:line1>3 Place L Pasteur</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/598EC0B6-AEB9-4323-95F7-5B4EFCDDF33E"><gtr:id>598EC0B6-AEB9-4323-95F7-5B4EFCDDF33E</gtr:id><gtr:name>Friedrich-Alexander University</gtr:name><gtr:address><gtr:line1>Schlossplatz 4</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6711BFCB-ACD5-4149-9C97-283269DF2778"><gtr:id>6711BFCB-ACD5-4149-9C97-283269DF2778</gtr:id><gtr:name>Mayo Clinic</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9218106A-E8CE-46A5-AABC-B4C8ED148690"><gtr:id>9218106A-E8CE-46A5-AABC-B4C8ED148690</gtr:id><gtr:name>University of Amsterdam</gtr:name><gtr:address><gtr:line1>Liaison Office</gtr:line1><gtr:line2>PO Box 19268</gtr:line2><gtr:line4>Amsterdam</gtr:line4><gtr:line5>Amsterdam</gtr:line5><gtr:postCode>1000 GG</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/395F850A-031E-45AD-817A-4C46D042B92C"><gtr:id>395F850A-031E-45AD-817A-4C46D042B92C</gtr:id><gtr:name>University of Cincinnati</gtr:name><gtr:address><gtr:line1>University of Cincinnati</gtr:line1><gtr:line2>2624 Clifton Avenue</gtr:line2><gtr:postCode>OH 45221-0</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E6DF5D67-D7D6-4891-9B77-959BE9D17DAC"><gtr:id>E6DF5D67-D7D6-4891-9B77-959BE9D17DAC</gtr:id><gtr:name>The Walter and Eliza Hall Institute of Medical Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D3EB34F1-7CAE-41B1-A951-98FA4BE48D2E"><gtr:id>D3EB34F1-7CAE-41B1-A951-98FA4BE48D2E</gtr:id><gtr:name>Janssen Biotech, Inc.</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/80DD41C8-30F5-4AB5-A2F4-F3285B212F89"><gtr:id>80DD41C8-30F5-4AB5-A2F4-F3285B212F89</gtr:id><gtr:name>Johns Hopkins Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/430A04B6-0F63-43BA-B78B-8DD4147CAF43"><gtr:id>430A04B6-0F63-43BA-B78B-8DD4147CAF43</gtr:id><gtr:name>University of Paris South 11</gtr:name><gtr:address><gtr:line1>Batiment 300</gtr:line1><gtr:line4>Orsay cedex</gtr:line4><gtr:line5>F-91405</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/103D3F37-4066-444D-93DA-A10CF99F10F5"><gtr:id>103D3F37-4066-444D-93DA-A10CF99F10F5</gtr:id><gtr:name>Austrian Academy of Sciences</gtr:name><gtr:address><gtr:line1>Lazarettgasse 14</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E913F6AA-9FFC-4300-83DB-799EC8F3A4E7"><gtr:id>E913F6AA-9FFC-4300-83DB-799EC8F3A4E7</gtr:id><gtr:name>University of Maryland</gtr:name><gtr:address><gtr:line1>University of Maryland</gtr:line1><gtr:postCode>20742</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A06FED91-B1C2-4601-A8BC-7FDF7DF5EF3D"><gtr:id>A06FED91-B1C2-4601-A8BC-7FDF7DF5EF3D</gtr:id><gtr:name>University Libre Bruxelles (Universit? Libre de Bruxelles ULB)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E68501E9-4C3B-4A78-B85D-88EF2B577390"><gtr:id>E68501E9-4C3B-4A78-B85D-88EF2B577390</gtr:id><gtr:name>University of California, San Francisco</gtr:name><gtr:address><gtr:line1>50 Beale Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/744EC7A2-0524-4F61-99B4-D4AEB6AE9854"><gtr:id>744EC7A2-0524-4F61-99B4-D4AEB6AE9854</gtr:id><gtr:name>Institute for Research on Health in the Working Environment (IRSET)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/416F403A-33BF-45CD-9639-25A0A29DB1E9"><gtr:id>416F403A-33BF-45CD-9639-25A0A29DB1E9</gtr:id><gtr:name>Gifu Pharmaceutical University</gtr:name><gtr:address><gtr:line1>5-6-1 Mitahora-Higashi</gtr:line1><gtr:postCode>502-8585</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B16D710A-5C40-44CA-A796-B37EC8935E99"><gtr:id>B16D710A-5C40-44CA-A796-B37EC8935E99</gtr:id><gtr:name>University of Michigan</gtr:name><gtr:address><gtr:line1>3003 S. State Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/13C67365-0236-4CCD-AF52-209DC562C679"><gtr:id>13C67365-0236-4CCD-AF52-209DC562C679</gtr:id><gtr:name>Research Institute for Diseases of the Chest Kyushi</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/064A41A2-AC2E-4ACC-A55B-D38D3434BD6A"><gtr:id>064A41A2-AC2E-4ACC-A55B-D38D3434BD6A</gtr:id><gtr:name>Queen's Medical Centre</gtr:name><gtr:address><gtr:line1>Queen's Medical Centre</gtr:line1><gtr:line2>Derby Rd</gtr:line2><gtr:postCode>NG7 2UH</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7B9C2D48-4CEC-46B1-89E7-DE5DCD1FA320"><gtr:id>7B9C2D48-4CEC-46B1-89E7-DE5DCD1FA320</gtr:id><gtr:name>Borstel Research Centre</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/58930F3F-9B16-4DC2-833F-C72033E77A1E"><gtr:id>58930F3F-9B16-4DC2-833F-C72033E77A1E</gtr:id><gtr:name>Boston Children's Hospital</gtr:name><gtr:address><gtr:line1>Boston Childrens Hospital</gtr:line1><gtr:line2>Karp Building</gtr:line2><gtr:line3>9th floor, Rm 09210 1 Blackfan Circle</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2E8E7A84-3BC7-4739-986D-C05FC31789B8"><gtr:id>2E8E7A84-3BC7-4739-986D-C05FC31789B8</gtr:id><gtr:name>Charit? - University of Medicine Berlin</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F77EAB28-C13B-419F-AC60-BA61966B71DE"><gtr:id>F77EAB28-C13B-419F-AC60-BA61966B71DE</gtr:id><gtr:name>University of Leipzig</gtr:name><gtr:address><gtr:line1>Ritterstrasse 26, D-04109 Leipzig</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9A22541F-DA58-481E-8D0C-C4BCF4EA030E"><gtr:id>9A22541F-DA58-481E-8D0C-C4BCF4EA030E</gtr:id><gtr:name>EMBL - European Bioinformatics Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB10 1SD</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/93B13D3A-863C-46E8-A4C7-1EE4759A7E9B"><gtr:id>93B13D3A-863C-46E8-A4C7-1EE4759A7E9B</gtr:id><gtr:name>Cleveland Clinic</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1EEF2886-0BDB-4D93-BEFD-16C71342AE0F"><gtr:id>1EEF2886-0BDB-4D93-BEFD-16C71342AE0F</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>McKenzie</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105178805"><gtr:id>D31EBCA2-A303-40E7-A9CD-FD23260BBC69</gtr:id><gtr:title>Investigation of immune and haematopoietic disorders</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105178805</gtr:grantReference><gtr:abstractText>The World Health Organisation estimates that in the region of 300 million people worldwide now suffer from asthma.
Allergic asthma is caused by an abnormal reaction to a variety of environmental agents, called allergens. This leads to long-term lung inflammation and an over-responsiveness of the airways. As the airways become narrowed and irritated, coughing, wheezing and shortness of breath occur.
The body is normally protected by its immune system, but during asthma it becomes inappropriately activated by allergens such as pollen and dust. We are trying to understand how the immune system is being controlled and identify points at which we may be able to block it and thereby improve asthma symptoms.
Cells of the immune system communicate by sending out protein messengers (called interleukins ) that are received by other cells and cause them to switch on specific functions ? for example to start producing mucus in the lung in response to irritation. We have discovered a new immune cell (ILC2) that plays a key role in receiving and sending out messages during asthma-like disease. 
Recently using mouse asthma models we have shown that blocking the action of Interleukin-25 (IL-25), asthma-like responses. We are now investigating the therapeutic potential of this approach for treating asthma.</gtr:abstractText><gtr:technicalSummary>Allergic asthma is characterised by uncontrollable airways hyperresponsiveness (AHR) induced by a variety of provocative stimuli and is associated with type-2 inflammatory infiltrates into the lungs. The number of sufferers has increased dramatically over recent decades and the World Health Organisation estimates that in the region of 300 million people worldwide suffer from this disorder. Genes residing on human chromosome 5q31-34 have been implicated in the induction and progression of several immune and haematopoietic disorders including asthma and allergy, autoimmunity, parasite susceptibility, and myelodysplasia. We combine information derived from the human and mouse genomes, with techniques to modify the mouse genome to identify and define the functions of disease susceptibility genes.
Using transgenic mouse models we have characterised fundamental inter-dependent roles for the type-2 cytokines interleukin-4 (IL-4), IL-5, IL-9 and IL-13 as mediators of asthma and allergy. More recently we have focussed on characterising critical molecules that initiate the type-2 response. These include IL-25 and IL-33. IL-25 is a member of the IL-17 family of cytokines and we have demonstrated an important role for IL-25 in protective immunity to infection and uncovered a critical role for IL-25 in airways hyperresponsiveness and inflammation. We developed a unique monoclonal antibody that blocks the interaction of IL-25 with its receptor, and administration of this antibody prevents airways hyperresponsiveness in a mouse model of allergic asthma. Importantly, since the anti-IL-25 antibody cross-reacts with human IL-25, blocking its interaction with the human IL-25 receptor, we have humanised this antibody in collaboration with MRC Technology, and are continuiing to validate this molecule in asthma models. 
It is becoming increasingly clear that innate immune cell types, in addition to the classical Th2 cells, can produce type-2 cytokines and that they may play critical roles in the initiation of the type-2 response. Using Il13-eGFP reporter mice, we discovered type-2 innate lymphoid cells (ILC2) and demonstrated that they are the predominant early source of the IL-13 critical for inducing expulsion of the helminth parasite, Nippostrongylus brasiliensis, following infection. ILC2 also expand in experimental models of asthma, where they represent an important source of type-2 cytokines. Our recent studies have indicated that ILC2 interact with dendritic cells and Th2 cells to potentiate type-2 immunity. We have shown that these type-2 ILCs develop from common lymphoid progenitors under signals from IL-7 and IL-33 and Notch. We have gone on to show that the transcription factors ROR, a relative of ROR t, and Bcl11b play important roles in ILC2 development.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>15927217</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Gifu Pharmaceutical University</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>IL-13 and periostin</gtr:description><gtr:id>FF8CF8F6-F221-4E15-85E9-2AB31174C0DA</gtr:id><gtr:impact>16815144</gtr:impact><gtr:outcomeId>B641F73F222-1</gtr:outcomeId><gtr:partnerContribution>Unpublished data</gtr:partnerContribution><gtr:piContribution>Reagents and scientific discussion</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Francisco</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Chitin and ILC2</gtr:description><gtr:id>49F042A6-0769-403F-BD6B-66307251AF37</gtr:id><gtr:impact>PMID:
 24613091</gtr:impact><gtr:outcomeId>5463221ce2f4f8.72650077-1</gtr:outcomeId><gtr:partnerContribution>intellectual, facilities</gtr:partnerContribution><gtr:piContribution>intellectual, reagents</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mayo Clinic</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Division of Allergic Diseases</gtr:department><gtr:description>IL-33 alternaria and ILC2</gtr:description><gtr:id>A1DA2FD4-12B6-4A46-9630-F5AB6ECC476A</gtr:id><gtr:impact>manuscript PMID:
 25015831</gtr:impact><gtr:outcomeId>msZo42Yuvri-1</gtr:outcomeId><gtr:partnerContribution>unpublished data</gtr:partnerContribution><gtr:piContribution>reagents and unpublished data, suggested experiments, editing manuscript</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Division of Immunology</gtr:department><gtr:description>IL-13 in asthma</gtr:description><gtr:id>06327CE8-6A8E-419D-A0BE-00094F008195</gtr:id><gtr:impact>19815118</gtr:impact><gtr:outcomeId>RuxS72vH9H9-1</gtr:outcomeId><gtr:piContribution>Reagents and scientific discussions</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Borstel Research Centre</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Infection Immunology</gtr:department><gtr:description>IL-13 in tuberculosis</gtr:description><gtr:id>4B84CEE5-4F06-48A8-8B6E-1965062E99BB</gtr:id><gtr:impact>PMID:
 24979482</gtr:impact><gtr:outcomeId>5463202f717b93.75685276-1</gtr:outcomeId><gtr:partnerContribution>Facilities, intellectual input</gtr:partnerContribution><gtr:piContribution>Reagents, intellectual input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Infection, Immunity and Inflammation</gtr:department><gtr:description>IL-33</gtr:description><gtr:id>9D7011C3-9D99-478D-B7F2-9D07F57087B0</gtr:id><gtr:impact>Publications 18802081 18667700 17853410 19506243 20139274 20473304 20634488</gtr:impact><gtr:outcomeId>316760956DE-1</gtr:outcomeId><gtr:partnerContribution>Data on IL-33</gtr:partnerContribution><gtr:piContribution>Mouse strains and tissues. Gene targeting.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Weatherall Institute of Molecular Medicine (WIMM)</gtr:department><gtr:description>human skin ILC2</gtr:description><gtr:id>B5F8B96D-1074-4F46-9C95-C8F1E095A7F8</gtr:id><gtr:impact>PMID:
 24323357
PMID:
 24388011 
PMID:
 26582946 
PMID:
 26299987</gtr:impact><gtr:outcomeId>54632eb3baf030.36832383-1</gtr:outcomeId><gtr:partnerContribution>Intellectual, reagents, equipment</gtr:partnerContribution><gtr:piContribution>Intellectual, reagents, equipment</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Haematology</gtr:department><gtr:description>SBDS</gtr:description><gtr:id>D2BFF7B1-22A9-437B-A18D-478D83536C4A</gtr:id><gtr:impact>Manuscript</gtr:impact><gtr:outcomeId>oA768um4419-1</gtr:outcomeId><gtr:partnerContribution>Unpublished data</gtr:partnerContribution><gtr:piContribution>Generation of reagents, experimental input, unpublished data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>helminth secretions and ILC2</gtr:description><gtr:id>9F8C7A2B-D9DB-4F89-827A-59A19055A7E6</gtr:id><gtr:impact>PMID:
 24496315</gtr:impact><gtr:outcomeId>5463236e87a9b3.84200707-1</gtr:outcomeId><gtr:partnerContribution>Intellectual, reagents, facilities</gtr:partnerContribution><gtr:piContribution>Intellectual, reagents, facilities</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>IL-33 and IgE</gtr:description><gtr:id>90BD92DA-C376-4BD9-96EE-746D9990193B</gtr:id><gtr:impact>Manuscript</gtr:impact><gtr:outcomeId>ryYjUPbAC5T-1</gtr:outcomeId><gtr:partnerContribution>Unpublished results</gtr:partnerContribution><gtr:piContribution>Reagents required to complete the study</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Boston Children's Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>ILC2 lung virus</gtr:description><gtr:id>99558BF2-52BB-4695-8511-691AC5914245</gtr:id><gtr:impact>manuscript</gtr:impact><gtr:outcomeId>K6hthqGyyGC-1</gtr:outcomeId><gtr:partnerContribution>unpublished data</gtr:partnerContribution><gtr:piContribution>reagents and unpublished data, suggested experiments, editing manuscript</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Michigan</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Type-2 cytokines and GVHD</gtr:description><gtr:id>7C86C9F6-79EF-4544-A16E-1BAD664B5777</gtr:id><gtr:impact>18410989</gtr:impact><gtr:outcomeId>5347923BEDC-1</gtr:outcomeId><gtr:partnerContribution>Unpublished data</gtr:partnerContribution><gtr:piContribution>Reagents and scientific discussion</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Trinity College Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Helminth infection</gtr:description><gtr:id>D5F7F552-FF56-407B-A784-A46F04F4D84A</gtr:id><gtr:impact>Publications 17407196 17372014 16606668 16365404 20130211 18981244</gtr:impact><gtr:outcomeId>37A8400A278-1</gtr:outcomeId><gtr:partnerContribution>Technical help with parasite models</gtr:partnerContribution><gtr:piContribution>Transgenic mouse models</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen's Medical Centre</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>il33 and il25 - airway contractility</gtr:description><gtr:id>742E786B-4DE6-4A2B-AE28-7E91EBE05C97</gtr:id><gtr:impact>PMID:
 23810766</gtr:impact><gtr:outcomeId>H4EpUpea4g3-1</gtr:outcomeId><gtr:partnerContribution>Contractility assay</gtr:partnerContribution><gtr:piContribution>Reagents, exptl design etc</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute for Research on Health in the Working Environment (IRSET)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>IL-33 and leishmania</gtr:description><gtr:id>2703D380-7597-46A4-AAFE-E203CF60D0D5</gtr:id><gtr:impact>PMID: 24045639</gtr:impact><gtr:outcomeId>ihQzKiPtwnw-1</gtr:outcomeId><gtr:partnerContribution>Reagents and information</gtr:partnerContribution><gtr:piContribution>New information on the role of IL-33 in infection</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Catholic University of Louvain</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>IL-13 interaction with IL-9</gtr:description><gtr:id>76703BE0-2C11-4375-8CC3-84C09DFFE30E</gtr:id><gtr:impact>17312173, 19342650</gtr:impact><gtr:outcomeId>4328BD88ED8-1</gtr:outcomeId><gtr:partnerContribution>Unpublished data</gtr:partnerContribution><gtr:piContribution>Reagents and scientific discussion</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Strathclyde</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Strathclyde Institute of Pharmacy &amp; Biomedical Sciences</gtr:department><gtr:description>IL-33 and Toxoplasma</gtr:description><gtr:id>A4DE38D7-E8B6-4FE5-A95B-AB3B3BFC6BB4</gtr:id><gtr:impact>19950183</gtr:impact><gtr:outcomeId>dsNZqP2Y3Tz-1</gtr:outcomeId><gtr:piContribution>Reagents and scientific discussions</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>TL1A and ILC2</gtr:description><gtr:id>31AE43BC-B849-4AAB-BAF2-FDC115CAB9B1</gtr:id><gtr:impact>PMID:
 24368564</gtr:impact><gtr:outcomeId>54633113360285.28132292-1</gtr:outcomeId><gtr:partnerContribution>Intellectual, reagents, facilities</gtr:partnerContribution><gtr:piContribution>Intellectual, reagents, facilities</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dendritic cells (MacDonald)</gtr:description><gtr:id>4F1883D9-76C0-4423-8133-E80ABF17300C</gtr:id><gtr:impact>PMID:
 25908537</gtr:impact><gtr:outcomeId>56d40850d7bf56.51275939-1</gtr:outcomeId><gtr:partnerContribution>Intellectual, reagents, facilities</gtr:partnerContribution><gtr:piContribution>Intellectual, reagents, facilities</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford University Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>5q</gtr:description><gtr:id>75F5080C-E440-4764-B145-89414EB01AAA</gtr:id><gtr:impact>20360478 19966810 20733155</gtr:impact><gtr:outcomeId>5138717520A-1</gtr:outcomeId><gtr:partnerContribution>Pre-publication data</gtr:partnerContribution><gtr:piContribution>Generation of mouse model of human 5q- disease</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Charit? - University of Medicine Berlin</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Department of Neuropathology</gtr:department><gtr:description>IL-13 and Cryptococcus</gtr:description><gtr:id>E087B440-AD4D-48A6-8C8F-A588B3105914</gtr:id><gtr:impact>17911623 19147811</gtr:impact><gtr:outcomeId>B6141BD4715-2</gtr:outcomeId><gtr:partnerContribution>Unpublished data</gtr:partnerContribution><gtr:piContribution>Reagents and scientific discussion</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Immunity and Infection</gtr:department><gtr:description>FALC ILCs (Caamano)</gtr:description><gtr:id>90B1902A-3B6B-4626-87D7-076B518DEF96</gtr:id><gtr:impact>PMID:
 26147686</gtr:impact><gtr:outcomeId>56d40754c4b6c6.52608555-1</gtr:outcomeId><gtr:partnerContribution>Intellectual, reagents</gtr:partnerContribution><gtr:piContribution>Intellectual, reagents</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Friedrich-Alexander University Erlangen-Nuremberg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>IL-33 and ILC in fibrosis</gtr:description><gtr:id>5C946F36-E4C1-40A5-B3EA-FE432B00D175</gtr:id><gtr:impact>PMID:
 23954132</gtr:impact><gtr:outcomeId>bZWu1t1eVqS-1</gtr:outcomeId><gtr:partnerContribution>New knowledge on the roles of IL-33 in fibrosis</gtr:partnerContribution><gtr:piContribution>Reagents and know-how, and manuscript writing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>Graf in brain macrophages</gtr:description><gtr:id>24660966-4D3A-43F3-9F65-D435B25C7ECD</gtr:id><gtr:impact>PMID 25189622</gtr:impact><gtr:outcomeId>54631e750f0a65.76273510-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input. Facilities.</gtr:partnerContribution><gtr:piContribution>Generation of gene-deficient mice and provision of experimental help and expertise</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>ST2 and heart inflammation</gtr:description><gtr:id>2F720418-5EB4-4FCB-8642-814DB374C44C</gtr:id><gtr:impact>17492053</gtr:impact><gtr:outcomeId>1276B0B15AC-1</gtr:outcomeId><gtr:partnerContribution>Unpublished data</gtr:partnerContribution><gtr:piContribution>Reagents and scientific discussion</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leipzig</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>IL-13 and Cryptococcus</gtr:description><gtr:id>FDC0B4F4-D604-4BEF-A80C-AC1B52FCE670</gtr:id><gtr:impact>17911623 19147811</gtr:impact><gtr:outcomeId>B6141BD4715-1</gtr:outcomeId><gtr:partnerContribution>Unpublished data</gtr:partnerContribution><gtr:piContribution>Reagents and scientific discussion</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Austrian Academy of Sciences</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:department>Research Centre for Molecular Medicine (CeMM)</gtr:department><gtr:description>IL-33 at birth - Knapp</gtr:description><gtr:id>F6463D9E-1AE2-471C-BAED-662236D96B0C</gtr:id><gtr:impact>PMID: 28228256</gtr:impact><gtr:outcomeId>58be77c79d0c83.25911481-1</gtr:outcomeId><gtr:partnerContribution>Expertise, intellectual contributions.</gtr:partnerContribution><gtr:piContribution>Expertise, reagents, hosting and training</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Walter and Eliza Hall Institute of Medical Research (WEHI)</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>T-bet and ILC3</gtr:description><gtr:id>87D4E066-5B50-432F-B176-4C86C0E66332</gtr:id><gtr:impact>PMID:
 23455676</gtr:impact><gtr:outcomeId>QgbQFqyw1bo-1</gtr:outcomeId><gtr:partnerContribution>Identification of Tbet in ILC3 deevlopment</gtr:partnerContribution><gtr:piContribution>experiments on ILC2</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cincinnati</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>IL-9 and food allergy</gtr:description><gtr:id>29D2142A-118E-443A-BD59-42D2513D72DD</gtr:id><gtr:impact>18378796</gtr:impact><gtr:outcomeId>94B3B465488-1</gtr:outcomeId><gtr:partnerContribution>Unpublished data</gtr:partnerContribution><gtr:piContribution>Reagents and scientific discussion</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cleveland Clinic</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Allergy and Clinical Immunology</gtr:department><gtr:description>IL-25 feedback and worms</gtr:description><gtr:id>C97DC71A-16C7-4571-92D4-68A5B6917F7A</gtr:id><gtr:impact>Manuscript</gtr:impact><gtr:outcomeId>PHQhmWR33qf-1</gtr:outcomeId><gtr:partnerContribution>unpublished data</gtr:partnerContribution><gtr:piContribution>reagents, experiments, manuscript editing</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins Medicine</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Division of Allergy and Clinical Immunology</gtr:department><gtr:description>SHP-1 and IL-13</gtr:description><gtr:id>E6E5FFBC-1DA5-4160-A93D-BD2F81C8854E</gtr:id><gtr:impact>18952567</gtr:impact><gtr:outcomeId>rGdqH49c7jq-1</gtr:outcomeId><gtr:piContribution>Reagents and scientific discussions</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>National Heart &amp; Lung Institute (NHLI)</gtr:department><gtr:description>Type-2 cytokines and asthma</gtr:description><gtr:id>99F8F095-BF83-48B1-A50C-21E9A747707D</gtr:id><gtr:impact>17883722 18417511</gtr:impact><gtr:outcomeId>AF088BB605A-1</gtr:outcomeId><gtr:partnerContribution>Unpublished data</gtr:partnerContribution><gtr:piContribution>Reagents and scientific discussion</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>IL-13 and mammary development</gtr:description><gtr:id>CC7C4EC4-88C8-4289-81F9-48EEAEDCEF0C</gtr:id><gtr:impact>17611223</gtr:impact><gtr:outcomeId>70A87C43BC9-1</gtr:outcomeId><gtr:partnerContribution>Unpublished data</gtr:partnerContribution><gtr:piContribution>Reagents and scientific discussion</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>ILK-25/IL-33 nasal polyps (Cousins/Till)</gtr:description><gtr:id>99CF059A-2E49-49C8-9F21-B1AD1D92C9C8</gtr:id><gtr:impact>PMID:
 26684290</gtr:impact><gtr:outcomeId>56d405e173ba36.59137975-1</gtr:outcomeId><gtr:partnerContribution>Access to human tissue samples</gtr:partnerContribution><gtr:piContribution>Reagents, know-how</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Research Institute for Diseases of the Chest Kyushi</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>SOCS induced IL-13</gtr:description><gtr:id>7CBD8988-7581-42F4-90B7-297AB5655E4B</gtr:id><gtr:impact>19299500</gtr:impact><gtr:outcomeId>Zmr93L9djEX-1</gtr:outcomeId><gtr:piContribution>Reagents and scientific discussions</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Janssen Biotech, Inc.</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>IL-25</gtr:description><gtr:id>8981CB75-D292-4487-AFC1-A6614D2C5E4B</gtr:id><gtr:impact>20200518</gtr:impact><gtr:outcomeId>ThtS8ErwARW-1</gtr:outcomeId><gtr:partnerContribution>reagents</gtr:partnerContribution><gtr:piContribution>reagents and unpublished data</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Maryland</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Division of Rheumatology &amp; Clinical Immunology</gtr:department><gtr:description>IL-33 protein</gtr:description><gtr:id>48BBCCC9-D511-4727-A827-3347FF398E71</gtr:id><gtr:impact>Manuscript</gtr:impact><gtr:outcomeId>eziJ1Fp5S3o-1</gtr:outcomeId><gtr:partnerContribution>Unpublished data</gtr:partnerContribution><gtr:piContribution>Reagents, unpublished data, manuscript editing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Paris Sud</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Institute of Biochemistry and Molecular and Cellular Biophysics (IBBMC)</gtr:department><gtr:description>IL-33 and LPS</gtr:description><gtr:id>80A6C77C-6EA6-4DD6-A9E2-74C2A7074D43</gtr:id><gtr:impact>19553541</gtr:impact><gtr:outcomeId>qWf9cU6Qsi5-1</gtr:outcomeId><gtr:piContribution>Reagents and scientific discussions</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Boston Children's Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>IL-33 and nuocytes in asthma and influenza</gtr:description><gtr:id>1BE1F7AA-B8E1-4DBD-AFF5-0C54150E5E9B</gtr:id><gtr:impact>Two manuscript</gtr:impact><gtr:outcomeId>Q95Dz4vZ7Lj-1</gtr:outcomeId><gtr:partnerContribution>Unpublished data</gtr:partnerContribution><gtr:piContribution>Unpublished data, reagents and suggested experiments</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Amsterdam</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>SIGNR1 and TB</gtr:description><gtr:id>C7542905-27DF-44EA-9187-C117241A29CF</gtr:id><gtr:impact>17224292, 18802081</gtr:impact><gtr:outcomeId>63E1F3EE3CC-1</gtr:outcomeId><gtr:partnerContribution>Unpublished data</gtr:partnerContribution><gtr:piContribution>Reagents and scientific discussion</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard T.H. Chan School of Public Health</gtr:department><gtr:description>IL-13 in glucose metabolism</gtr:description><gtr:id>B81198C2-8BFB-4FA9-9A02-DCF2533C0697</gtr:id><gtr:impact>PMID:
 23257358</gtr:impact><gtr:outcomeId>KiHPvvKNbCH-1</gtr:outcomeId><gtr:partnerContribution>discovery of a role for IL-13 in glucose production</gtr:partnerContribution><gtr:piContribution>Reagents, and assessing the role of ILC2</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Libre Bruxelles (Universit? Libre de Bruxelles ULB)</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:department>Laboratory of Experimental Gastroenterology, Erasme Hospital</gtr:department><gtr:description>ST2 in pancreatitis</gtr:description><gtr:id>FF3B15A2-29FE-4CDD-AE59-7CBDB81B34EF</gtr:id><gtr:impact>Manuscript</gtr:impact><gtr:outcomeId>kiePaPk3BRJ-1</gtr:outcomeId><gtr:partnerContribution>unpublished data</gtr:partnerContribution><gtr:piContribution>reagents, unpublished data, manuscript editing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Friedrich-Alexander University Erlangen-Nuremberg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Th9 cells in epithelial cells</gtr:description><gtr:id>0B4745CA-1959-453A-9DE6-E160554F4C3B</gtr:id><gtr:impact>PMID:
 24908389
PMID:
 25838986</gtr:impact><gtr:outcomeId>546321437414b7.43456715-1</gtr:outcomeId><gtr:partnerContribution>Intellectual, reagents, facilities</gtr:partnerContribution><gtr:piContribution>Intellectual, reagents, facilities</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Michigan</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>IL-13 and BOS</gtr:description><gtr:id>63C90DB7-E6C8-4106-8078-1BAE6D7CE238</gtr:id><gtr:impact>16816360</gtr:impact><gtr:outcomeId>5A27A76C744-1</gtr:outcomeId><gtr:partnerContribution>Unpublished data</gtr:partnerContribution><gtr:piContribution>Reagents and scientific discussion</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>EMBL European Bioinformatics Institute (EMBL - EBI)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>single cell rna Th2</gtr:description><gtr:id>99989B43-46B8-4149-864B-86345841365B</gtr:id><gtr:impact>PMID:
 24813893</gtr:impact><gtr:outcomeId>546321c3c2fa46.02302394-1</gtr:outcomeId><gtr:partnerContribution>intellectual, facilities,</gtr:partnerContribution><gtr:piContribution>intellectual, facilities, reagents</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Trinity College Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>ILC2 fibrosis and obesity</gtr:description><gtr:id>C731B37C-5252-411A-A2D8-DDD3BF500369</gtr:id><gtr:impact>PMID:
 24166975
PMID:
 24344271
PMID:
 26490658</gtr:impact><gtr:outcomeId>546331f23250e5.49213984-1</gtr:outcomeId><gtr:partnerContribution>intellectual, reagents, facilities</gtr:partnerContribution><gtr:piContribution>intellectual, reagents, facilities</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Speaker</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F7132134-5442-4D57-B9D4-3BDAA87D6E4B</gtr:id><gtr:impact>Presentation to clinicians on the role of IL-25 in asthma and allergy.

None as yet!</gtr:impact><gtr:outcomeId>DB4F4E9E615</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Biomedical opportunities in deep sequencing of immunological repertoires EMBL-EBI Workshop, HInxton - Cristina Rada</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DE26786D-441E-4FA7-AA4F-7279D45C943F</gtr:id><gtr:impact>Cristina Rada gave a presentation at the EMBL-EBI Industry workshop on Biomedical opportunities in deep sequencing of immunological repertoires. As well as the audience the workshop was linked to online participants. Debate and discussion followed. The workshop series is part of EBI's industry programme which links industry and academia.</gtr:impact><gtr:outcomeId>58b04f22665030.86125695</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:url>http://www.ebi.ac.uk/industry</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Work experience - school age</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6B969986-2451-4EE3-A18F-9D2CF1F02CEF</gtr:id><gtr:impact>School children attended for work experience.</gtr:impact><gtr:outcomeId>58bea684d6ba64.45063663</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar at Saarbruken University, Germany - Cristina Rada</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8F5C1763-C5A3-40DD-A191-B7D5EF0AEC96</gtr:id><gtr:impact>Cristina Rada was invited to give a seminar to scientific colleagues at Saarbrueken University. Audience was a mixture of postdocs, students and senior scientists. Follwed by debate and discussions.</gtr:impact><gtr:outcomeId>58b04a9129b751.85885954</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hosting school students</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>1C3A6542-BF88-46E0-A8F6-2BD317514F9A</gtr:id><gtr:impact>The pupils have been highly enthusiastic and we are now taking three students per year.

For the past 3 years we have hosted GCSE and pre-A level students to give them experience of lab-based science. We have received considerable impact from the individuals and they have been able to ask for information on university courses and careers.</gtr:impact><gtr:outcomeId>54633575cfaf91.88633248</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Editor of LMB Brochure 2016 - Cristina Rada</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8ABEB107-DD71-422A-8553-E3061214B262</gtr:id><gtr:impact>Cristina Rada edited the 2016 LMB brochure which is the LMB's main printed communication tool for the general public. It is also used for recruitment of PhD students and providing information for academic visitors, policymakers and general visitors.</gtr:impact><gtr:outcomeId>58ac80448914c4.31287432</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sawston Village College visit to Royal Society Exhibition by Cristina Rada</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>987DC4BE-6B70-4D3D-B23C-2015518391E4</gtr:id><gtr:impact>Taking up to 20 GSCE science students to the annual Royal Society Summer Exhibition in London. This is to encourage students to take A level science subjects and the excite their curiosity for scientific learning.</gtr:impact><gtr:outcomeId>58ac817044c3f6.31860951</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ANR Scientific Evaluation Committee (CE12, Genetics, genomics, gene expression, regulator RNAs), France - Cristina Rada</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D48D2EFB-8055-49D8-B9F7-C863CDA6E9D1</gtr:id><gtr:impact>Cristina Rada was a member of the expert panel assessing research at the Frendch National Research Agency (ANR) which provides funding for project-based research in all fields of science - for both basic and applied research - to public research organisations and universities, as well as to private companies (including SMEs). Employing a method based on competitive peer reviews compliant with international standards, ANR provides the scientific community with instruments and programmes promoting creativity and openness, and stimulate new ideas and partnerships, particularly between academia and industry. Its activity also contributes to enhancing the competitiveness and the influence of French research in Europe and across the world.
Since 2010, ANR has also been the lead manager of the Investments for the Future programme in the field of higher education and research, in charge of project selection, funding and monitoring.</gtr:impact><gtr:outcomeId>58b050a96b38b4.22773140</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.agence-nationale-recherche.fr/en/about-anr/about-the-french-national-research-agency/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Non-scientist seminar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EB77E2DA-7247-453C-80B2-1579059F4147</gtr:id><gtr:impact>Seminar aimed at highlighting research on asthma to general public and MRC non-scientific support staff. Generated discussion and questions about new potential therapeutics in asthma.

N/A</gtr:impact><gtr:outcomeId>Vn4kTJYtu6u</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Speaker</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BA2BE9BC-BB28-4B30-9641-85FFB1FD9B0D</gtr:id><gtr:impact>Presentation to clinicians at the European Respiratory Society on the therapeutic potential of blocking IL-25

None as yet</gtr:impact><gtr:outcomeId>0DDC5B03D22</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar at King's College London - Cristina Rada</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>022F180C-8ADE-4A17-94AE-EC1D6B7B43DD</gtr:id><gtr:impact>Cristina Rada was invited to give a seminar to scientific colleagues at King's college, London. Audience was a mixture of postdocs, students and senior scientists. Follwed by debate and discussions.</gtr:impact><gtr:outcomeId>58b049c9cdde57.54619047</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>HCERES President of the Evaluation Committee of CNRS Unit, Limoges, France - Cristina Rada</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8F3F11B8-3649-4EC0-9A0B-89F5CC83F0A1</gtr:id><gtr:impact>Cristina Rada was the Chair of a Site Visit Committee at CNRS Unit, Limoges, France for their evaluation of research and teaching in immunology.</gtr:impact><gtr:outcomeId>58b052fd705e29.39411655</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.hceres.com/Evaluation-procedures/List-of-experts-who-have-taken-part-in-an-evaluation</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>IAT meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4A0D8208-1056-4F69-B0B8-EE4FF3512195</gtr:id><gtr:impact>150 animal technicians attended the talk on transgenics in asthma research at the regional IAT meeting. This generated discussion about the contribution of technicians in such projects.

Excellent feedback from the audience</gtr:impact><gtr:outcomeId>KGRiPra4VTg</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar, Institute Curie, Paris, France - Cristina Rada</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9090BB1A-FCF0-4C57-85A0-B10EA85D320A</gtr:id><gtr:impact>Cristina Rada was invited to give a seminar to scientific colleagues at Institut Curie. Audience was a mixture of postdocs, students and senior scientists. Follwed by debate and discussions.</gtr:impact><gtr:outcomeId>58b0494ad88938.17302537</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>387000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:department>Janssen Pharmaceuticals</gtr:department><gtr:description>Commercial funds</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Johnson &amp; Johnson</gtr:fundingOrg><gtr:id>8F993C24-D0D4-47A9-952E-B3F2AB345AD4</gtr:id><gtr:outcomeId>muHGZnA33w3</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>116933</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRCT Development Gap Funding</gtr:description><gtr:end>2010-06-02</gtr:end><gtr:fundingOrg>MRC Technology (MRCT)</gtr:fundingOrg><gtr:id>81342CBE-A4E5-4D7E-82FF-14D8ECD77272</gtr:id><gtr:outcomeId>DF596717BB30</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>296000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>GlaxoSmithKline Medicines Research Centre</gtr:department><gtr:description>GSK Agreement 100042097</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:fundingRef>100042097</gtr:fundingRef><gtr:id>7E95A03A-5BEF-4980-A891-ACDE10FFC19E</gtr:id><gtr:outcomeId>56d090aab32a47.37752727</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>140000</gtr:amountPounds><gtr:country>Canada</gtr:country><gtr:currCode>CAD</gtr:currCode><gtr:currCountryCode>Canada</gtr:currCountryCode><gtr:currLang>en_CA</gtr:currLang><gtr:description>Banting Fellowship</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Canadian Institutes of Health Research</gtr:fundingOrg><gtr:fundingRef>201211BPF-293444-193128</gtr:fundingRef><gtr:id>7AF7BC8B-7E46-4B0D-8A71-B95731897238</gtr:id><gtr:outcomeId>tN4NK7tw8LP</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>62320</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRCT Development Gap Funding</gtr:description><gtr:end>2008-06-02</gtr:end><gtr:fundingOrg>MRC Technology (MRCT)</gtr:fundingOrg><gtr:id>CD482F02-F719-4AE6-9406-1024F9823249</gtr:id><gtr:outcomeId>52DA325762A0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>140826</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Asthma UK Project Grant</gtr:description><gtr:end>2010-04-02</gtr:end><gtr:fundingOrg>Asthma UK</gtr:fundingOrg><gtr:id>8895B746-ECD5-4F60-A630-C69D917500E4</gtr:id><gtr:outcomeId>0BCD3134B6E0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>155000</gtr:amountPounds><gtr:country>Singapore, Republic of</gtr:country><gtr:currCode>SGD</gtr:currCode><gtr:currCountryCode>Singapore</gtr:currCountryCode><gtr:currLang>en_SG</gtr:currLang><gtr:description>A*Star Singapore National Science Scholarship (Hwang)</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Agency for Science, Technology and Research (A*STAR)</gtr:fundingOrg><gtr:id>F917C153-64F6-4B0E-AFBE-76B965D397B5</gtr:id><gtr:outcomeId>56d43c6a1f04d7.73116667</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>American Asthma Foundation Programme grant</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>American Asthma Foundation</gtr:fundingOrg><gtr:id>FE64D24F-835F-4F66-B5F5-B79FB981ABF3</gtr:id><gtr:outcomeId>VVyoeF7xiGA0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>72000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Darwin Trust of Edinburgh</gtr:department><gtr:description>C&amp;eacute;sar Milstein Memorial studentship of the Darwin Trust, Edinburgh</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>British Society for the History of Science (BSHS)</gtr:fundingOrg><gtr:id>61FCA7DE-36E0-4F65-A276-71AD83E78168</gtr:id><gtr:outcomeId>1EBA79AB7C80</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>163450</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Leukaemia and Lymphoma Research project grant</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>5B314304-FD06-493B-B4B5-214F162C9AA4</gtr:id><gtr:outcomeId>j9xQyXtAt3Z0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2079643</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Senior Investigator</gtr:description><gtr:end>2018-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>100963/Z/12/Z</gtr:fundingRef><gtr:id>BBE81E2B-B715-4069-9069-1285349FF987</gtr:id><gtr:outcomeId>MYw7Ezyhdsw</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1473000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:department>Janssen Pharmaceuticals</gtr:department><gtr:description>Commercial funding</gtr:description><gtr:end>2016-05-02</gtr:end><gtr:fundingOrg>Johnson &amp; Johnson</gtr:fundingOrg><gtr:id>742B451F-5145-40B0-BA3E-4AF25B3359F6</gtr:id><gtr:outcomeId>bCMM7vsDLxU</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>123312</gtr:amountPounds><gtr:country>Hong Kong, Special Administrative Region of China</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Croucher Cambridge International Scholarship</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>The Croucher Foundation</gtr:fundingOrg><gtr:id>7989B9EE-CD6B-4BF0-8BBF-4A5DFFF8985F</gtr:id><gtr:outcomeId>58b9686b38eb39.78506131</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>330162</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Research and Development AstraZeneca</gtr:department><gtr:description>AstraZeneca/LMB Blue Skies Initiative</gtr:description><gtr:end>2018-04-02</gtr:end><gtr:fundingOrg>AstraZeneca</gtr:fundingOrg><gtr:id>09C8FA5D-8B57-4F61-AF50-47ECCCAFBFEB</gtr:id><gtr:outcomeId>56d09209496b16.35424064</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>IL-17BR-deficient mouse</gtr:description><gtr:grantRef>MC_U105178805</gtr:grantRef><gtr:id>36EA488B-AB89-4293-8CD0-6055852D280E</gtr:id><gtr:impact>N/A</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>58bea82bebf140.58682555</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>Licencing IL-17BR-deficient mouse</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>An antibody that blocks the bioactivity of IL-25. This has now been humanised and licensed for development.</gtr:description><gtr:grantRef>MC_U105178805</gtr:grantRef><gtr:id>02E74937-AAA2-467B-A0F2-ACF4FC8BF593</gtr:id><gtr:impact>Humanised monoclonal antibody to the IL-25 which has potential as a therapeutic agent for the treatment of allergic asthma. Patent granted</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>BF0E57F0BE3</gtr:outcomeId><gtr:patentId>EP2144934</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Anti-IL-25</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Licencing ST2-deficient mouse</gtr:description><gtr:grantRef>MC_U105178805</gtr:grantRef><gtr:id>BFB0053A-41D7-494F-BA92-080D85CA1F26</gtr:id><gtr:impact>N/A</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>58bea7eee2f124.82972819</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>Licencing ST2-deficient mouse</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>IL-4/13-deficient mouse</gtr:description><gtr:grantRef>MC_U105178805</gtr:grantRef><gtr:id>F3C7AA8C-3F61-40A5-A6C4-DFA9CF7BD59A</gtr:id><gtr:impact>N/A</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>58bea8659b8507.36859573</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>Licencing IL-4/13-deficient mouse</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Meeting with Head of Office of Life Sciences to discuss the case for supporting science</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7CAA5AB7-E0C2-4EE6-BE48-432761132EBB</gtr:id><gtr:outcomeId>56d40e414c3a93.25884241</gtr:outcomeId><gtr:type>Implementation circular/rapid advice/letter to e.g. Ministry of Health</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Meeting with Stuart Agnew MEP to advise on EU parliamentary debate on animal use in scientific research</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>B935D723-14CC-49B7-901B-91DCC7338918</gtr:id><gtr:outcomeId>56d40cb7a72765.18755783</gtr:outcomeId><gtr:type>Implementation circular/rapid advice/letter to e.g. Ministry of Health</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>We have developed an antibody that specifically blocks the biological activity of IL-25, preventing many of the features of asthma in mouse models. The antibody has been humanised in collaboration with MRCT.</gtr:description><gtr:id>6A2B1793-3712-40A5-BEF6-939FAAD0873B</gtr:id><gtr:impact>This antibody has been licensed for development as a therapeutic.</gtr:impact><gtr:outcomeId>41298D27C39</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Anti-IL-25 antibody</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2008</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Knockin mouse in which the citrine fluorescence gene has been inserted into the IL-33 gene. This allows researchers to visualise IL-33 gene expression during infection and disease models.</gtr:description><gtr:id>3E87EF35-3642-4114-A5DE-98BC475D1797</gtr:id><gtr:impact>publication of novel data</gtr:impact><gtr:outcomeId>koC9Ldrontf</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>IL-33 citrine reporter mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Mice lacking T1/ST2 (IL-33 receptor)</gtr:description><gtr:id>85AD895B-D5D8-47C2-8024-9F2289947C19</gtr:id><gtr:impact>Used in asthma and immunology research.</gtr:impact><gtr:outcomeId>A2802866A27</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>T1/ST2-deficient (IL-33 receptor) mice</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Mice with combined deficiencies in type-2 cytokines</gtr:description><gtr:id>D1F97A07-81D4-4C2B-9E6B-081EAD114097</gtr:id><gtr:impact>Allow clear demarcation of involvement of type-2 cytokine-independent immune pathways in asthma and immunology.</gtr:impact><gtr:outcomeId>857D07EA65F</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>type 2 cytokine-deficient mice</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Monoclonal antibody against IL-17BR</gtr:description><gtr:id>F4DBDE85-C8D0-4B44-B8F0-2E27E5274B5E</gtr:id><gtr:impact>This antibody is able to inhibit the biological activity of IL-25 in experimental asthma</gtr:impact><gtr:outcomeId>PZKcHMDnmYk</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Monoclonal antibody against IL-17BR</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>development of mice in which ILC2 are absent</gtr:description><gtr:id>197CB693-F95A-4671-A533-9CF7B21828CC</gtr:id><gtr:impact>The discovery of roles ILC2 in adaptive immunity.</gtr:impact><gtr:outcomeId>546338275a72c3.34494689</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Rora-flox ILC2 deletion mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Mice lacking SIGN-R1 molecule</gtr:description><gtr:id>81C1498A-6318-4621-A35C-EA5341BD8846</gtr:id><gtr:impact>Used in the analysis of infection models</gtr:impact><gtr:outcomeId>99B91D010B7</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>SIGN-R1-deficient mice</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Monoclonal antibody against IL-25</gtr:description><gtr:id>A5C49315-9F31-4509-8A88-8F28B51B7BBE</gtr:id><gtr:impact>This antibody has been licensed for commercial development as a therapeutic.</gtr:impact><gtr:outcomeId>28A253329EB</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Monoclonal antibody against IL-25</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Development of mice in which ILC2 can be deleted temporally using diphtheria toxin</gtr:description><gtr:id>8CDF4D41-BA3C-49AD-96C3-ECAA8C5AE1C4</gtr:id><gtr:impact>Discovery of a role for ILC2 in adaptive immune activation</gtr:impact><gtr:outcomeId>5463388b3483f1.25726450</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>iCOS-T mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Mice lacking the cytokine IL-25</gtr:description><gtr:id>CB83C185-1099-4D9E-9135-1B3B114516DE</gtr:id><gtr:impact>These mice have been supplied to several laboratories around the world for asthma research.</gtr:impact><gtr:outcomeId>A8B1BFAC735</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Interleukin-25-deficient mice</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Insertion of fluorescent reporter into IL-13 gene</gtr:description><gtr:id>6DB9EF17-E214-428E-A0BD-3685110AC6C4</gtr:id><gtr:impact>Tracking IL-13 producing nuocytes in experimental asthma</gtr:impact><gtr:outcomeId>kpiydHyt6Ct</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>IL-13 reporter mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>IL-17BR-deficient mice</gtr:description><gtr:id>31B38CA0-3873-4C5F-A4D4-9D3D6500A595</gtr:id><gtr:impact>The functional characterisation of a new immune cells - the nuocyte.</gtr:impact><gtr:outcomeId>s1GCS6h6R5P</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>IL-17BR-deficient mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>43C76D83-4E05-472C-9082-805E17FA1557</gtr:id><gtr:title>The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a6c6144d58e1219cffe64c94ca387bd"><gtr:id>2a6c6144d58e1219cffe64c94ca387bd</gtr:id><gtr:otherNames>Meylan F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>545a5b5eb0a7f9.17247830</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38DE06AE-6B7F-4233-830C-A9D52DEC0A55</gtr:id><gtr:title>Innate lymphoid cells--a proposal for uniform nomenclature.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f02af608d2751c6b3a1ce7d79ca5555"><gtr:id>4f02af608d2751c6b3a1ce7d79ca5555</gtr:id><gtr:otherNames>Spits H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>pm_14176_26_23348417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF0E4B91-5A58-4F71-8357-14F2856DABC6</gtr:id><gtr:title>IL-33 and thymic stromal lymphopoietin mediate immune pathology in response to chronic airborne allergen exposure.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a3f4777f64c9ebd297ab7bfc5e12386"><gtr:id>5a3f4777f64c9ebd297ab7bfc5e12386</gtr:id><gtr:otherNames>Iijima K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>545a5b5e1218d5.50732412</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F48D296C-E500-4D5B-BA84-989046DE0161</gtr:id><gtr:title>Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b6ce39b7f477bffdf3ee1b97bcd2536"><gtr:id>8b6ce39b7f477bffdf3ee1b97bcd2536</gtr:id><gtr:otherNames>Halim TY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>545a5b5f502800.20968908</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33EB2BDA-6C5F-491D-9FC3-88CFE1E00363</gtr:id><gtr:title>Erratum to: Single cell analysis of CD4+ T cell differentiation reveals three major cell states and progressive acceleration of proliferation.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6b5a13fd7b61c54fb4b0fc9f270bbc5"><gtr:id>d6b5a13fd7b61c54fb4b0fc9f270bbc5</gtr:id><gtr:otherNames>Proserpio V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>58b07846e9a452.46235527</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E96D241E-21D2-425B-9DE0-48D4099CC6D7</gtr:id><gtr:title>Impaired basophil induction leads to an age-dependent innate defect in type 2 immunity during helminth infection in mice.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41f44eda17b7e78f1fdc3a28d67ee433"><gtr:id>41f44eda17b7e78f1fdc3a28d67ee433</gtr:id><gtr:otherNames>Nel HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>EMfPpCWwyfV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C61F784-1799-4832-AA14-103F106F412F</gtr:id><gtr:title>Bcl11b is essential for group 2 innate lymphoid cell development.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/191489dc6bbd83835665b20955d875a3"><gtr:id>191489dc6bbd83835665b20955d875a3</gtr:id><gtr:otherNames>Walker JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>56c4b849a858b8.80430371</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63704E80-E2FE-420D-BB12-BE32292874B5</gtr:id><gtr:title>Endogenous IL-13 plays a crucial role in liver granuloma maturation during Leishmania donovani infection, independent of IL-4Ra-responsive macrophages and neutrophils.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e7b119db49b9d6b190ff3a600c1203a"><gtr:id>1e7b119db49b9d6b190ff3a600c1203a</gtr:id><gtr:otherNames>McFarlane E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>riQ8UDLev5A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E409FEB9-4906-49F5-A497-F5B5CBAEF7B1</gtr:id><gtr:title>Type-2 innate lymphoid cells in human allergic disease.</gtr:title><gtr:parentPublicationTitle>Current opinion in allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63ff2ec91e39761c3b838f4287d94b6e"><gtr:id>63ff2ec91e39761c3b838f4287d94b6e</gtr:id><gtr:otherNames>Barlow JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1473-6322</gtr:issn><gtr:outcomeId>545a5b5fcf6dd5.03878275</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0813BB5-ED8E-4967-903F-FA7BE9578EA6</gtr:id><gtr:title>Innate lymphoid cells in immunity and disease.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77aa99db23304bf7dda288d027b380d8"><gtr:id>77aa99db23304bf7dda288d027b380d8</gtr:id><gtr:otherNames>Hwang YY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>pm_14176_26_23456833</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E72010F-6588-45B7-A39F-61D2790C8D02</gtr:id><gtr:title>IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dab3a52525a13cb27fc9cf7d9b96ed74"><gtr:id>dab3a52525a13cb27fc9cf7d9b96ed74</gtr:id><gtr:otherNames>M?ller U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>CF2D817E9FA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABCE1FFC-8A0F-4904-B36E-ACE183BF41CB</gtr:id><gtr:title>Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b23760e0b0435bdde8730a50e1f439f7"><gtr:id>b23760e0b0435bdde8730a50e1f439f7</gtr:id><gtr:otherNames>Eberl G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>56c4b84b217d63.16616195</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F64E1BDD-53B9-404F-9623-622E44B66B79</gtr:id><gtr:title>Obligatory role for interleukin-13 in obstructive lesion development in airway allografts.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db4818f8ba7e7fa676524ed68daf2197"><gtr:id>db4818f8ba7e7fa676524ed68daf2197</gtr:id><gtr:otherNames>Lama VN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>AF80FE2B745</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>827C14D6-1E10-4D17-A37E-595967C0E550</gtr:id><gtr:title>The helminth T2 RNase ?1 promotes metabolic homeostasis in an IL-33- and group 2 innate lymphoid cell-dependent mechanism.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfc426fe0d06111dd3a01914016493e7"><gtr:id>cfc426fe0d06111dd3a01914016493e7</gtr:id><gtr:otherNames>Hams E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>56c4b84b7ee7c0.45887335</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8472FD8-9BD4-4444-872B-D1F7A7F258D0</gtr:id><gtr:title>IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba7dc4c284b3647cbb6aba7027a2830b"><gtr:id>ba7dc4c284b3647cbb6aba7027a2830b</gtr:id><gtr:otherNames>Sanada S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>CE20947536F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F59E0C24-7A6D-413E-BD57-54AEE90BC99E</gtr:id><gtr:title>Inflammation-induced formation of fat-associated lymphoid clusters.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85e0f1e9b568e36214ff9a0fef415598"><gtr:id>85e0f1e9b568e36214ff9a0fef415598</gtr:id><gtr:otherNames>B?n?zech C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>56c4b84ae4b121.37145012</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58A35C3E-9DFB-40B7-B2B5-364F4176B381</gtr:id><gtr:title>The messenger between worlds: the regulation of innate and adaptive type-2 immunity by innate lymphoid cells.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4694996772177047ce1903b2332f9290"><gtr:id>4694996772177047ce1903b2332f9290</gtr:id><gtr:otherNames>Scanlon ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>56c4b84ba63464.20746141</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4340A251-5466-4DB7-81B5-A2F3AD120805</gtr:id><gtr:title>Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fdcdecde1e6b0fc0dca13d046b13fffe"><gtr:id>fdcdecde1e6b0fc0dca13d046b13fffe</gtr:id><gtr:otherNames>Miller AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn><gtr:outcomeId>sscM46e5YJv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCD409BB-3FAA-46C9-B864-441A017FA096</gtr:id><gtr:title>A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63ff2ec91e39761c3b838f4287d94b6e"><gtr:id>63ff2ec91e39761c3b838f4287d94b6e</gtr:id><gtr:otherNames>Barlow JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>7D1534522CE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>147B6692-6C63-4D8E-B67E-7C60D9D0ECFD</gtr:id><gtr:title>T1/ST2 expression on Th2 cells negatively regulates allergic pulmonary inflammation.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e587c96dfcc954d413c5181c5c79835"><gtr:id>0e587c96dfcc954d413c5181c5c79835</gtr:id><gtr:otherNames>Mangan NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>A3A01A81F08</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A99BBB36-E80B-4706-88A4-B4829831F7AD</gtr:id><gtr:title>Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in na&amp;iuml;ve mice.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63e638ecaaad0ff3875bc715972a1fc2"><gtr:id>63e638ecaaad0ff3875bc715972a1fc2</gtr:id><gtr:otherNames>Komai-Koma M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>pm_14176_26_22702477</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B54822EB-0950-4F83-A4A1-F95C94FA5DC6</gtr:id><gtr:title>A critical role of SHP-1 in regulation of type 2 inflammation in the lung.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76500b01c09331623b78e0075fdd14a2"><gtr:id>76500b01c09331623b78e0075fdd14a2</gtr:id><gtr:otherNames>Oh SY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1044-1549</gtr:issn><gtr:outcomeId>D69zFnqNv1o</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8656024E-86C6-425A-A237-39D2595BC2DC</gtr:id><gtr:title>IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/688b5e014b27d12a7474ab3cf884492b"><gtr:id>688b5e014b27d12a7474ab3cf884492b</gtr:id><gtr:otherNames>Forbes EE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>0F92DCF7855</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1D9260C-4725-447B-8807-C20547CB1117</gtr:id><gtr:title>Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f05f075d4358c2d78b4fd9bd1b68a270"><gtr:id>f05f075d4358c2d78b4fd9bd1b68a270</gtr:id><gtr:otherNames>Saunders SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>56c4b84b4bf3b1.23608756</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78F69D4D-99C8-4E72-A083-E5307680A29C</gtr:id><gtr:title>IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f973b6970aa4bd06f6bcdfe946d97366"><gtr:id>f973b6970aa4bd06f6bcdfe946d97366</gtr:id><gtr:otherNames>Floudas A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5a8d9837a0eb52.04190082</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>915F97BC-1FF3-4520-A839-79773C825DD7</gtr:id><gtr:title>T2 cell development and function.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/191489dc6bbd83835665b20955d875a3"><gtr:id>191489dc6bbd83835665b20955d875a3</gtr:id><gtr:otherNames>Walker JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>5a8d9839075709.17126923</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC414484-D70E-4A5E-B959-DD5CBF884AA9</gtr:id><gtr:title>Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/443614f23ce67da889848c1567a59920"><gtr:id>443614f23ce67da889848c1567a59920</gtr:id><gtr:otherNames>Finch AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>a9NQhJNy2Ka</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E29B280-4936-41C3-9418-E0989265982C</gtr:id><gtr:title>IL-33 exacerbates antigen-induced arthritis by activating mast cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8d926f151e1a5ca9c91291369227789"><gtr:id>e8d926f151e1a5ca9c91291369227789</gtr:id><gtr:otherNames>Xu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>87E800F1E54</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B841C7F-579A-4975-83BA-C90BAC9DE725</gtr:id><gtr:title>The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b096e8aa0cd785493d0ffa073dbb71b9"><gtr:id>b096e8aa0cd785493d0ffa073dbb71b9</gtr:id><gtr:otherNames>Damgaard RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>58b078466fa847.95356987</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFAB0196-783B-4B64-A87F-25050523AFF0</gtr:id><gtr:title>New insights into 5q- syndrome as a ribosomopathy.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63ff2ec91e39761c3b838f4287d94b6e"><gtr:id>63ff2ec91e39761c3b838f4287d94b6e</gtr:id><gtr:otherNames>Barlow JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>dtmA77amjSx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB554175-3DF3-48F3-A10A-D55AD544DED3</gtr:id><gtr:title>Nuocytes and beyond: new insights into helminth expulsion.</gtr:title><gtr:parentPublicationTitle>Trends in parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70a83ce11c46bd184c75e59dcc3d7fd5"><gtr:id>70a83ce11c46bd184c75e59dcc3d7fd5</gtr:id><gtr:otherNames>Neill DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-4922</gtr:issn><gtr:outcomeId>nTfu1bHFD9Y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B839213-D034-4DE3-9D10-10AB126C42D6</gtr:id><gtr:title>IL-4/IL-13-dependent alternative activation of macrophages but not microglial cells is associated with uncontrolled cerebral cryptococcosis.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c371c997ec709c88b371e4b82e07668"><gtr:id>7c371c997ec709c88b371e4b82e07668</gtr:id><gtr:otherNames>Stenzel W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>r2w3tukK5g9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3C067E5-0B8C-4CB2-B4B7-F78BD46BA50E</gtr:id><gtr:title>Epidermal Growth Factor Receptor Expression Licenses Type-2 Helper T Cells to Function in a T Cell Receptor-Independent Fashion.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d21d3ca6cb22d160b881b59417216b1"><gtr:id>5d21d3ca6cb22d160b881b59417216b1</gtr:id><gtr:otherNames>Minutti CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>5a8d9838b15952.33796689</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F0D27E0-91C6-43D8-8492-EBCDDB213757</gtr:id><gtr:title>ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/907af3d90ebbd9277e3ebd5fbe7283b6"><gtr:id>907af3d90ebbd9277e3ebd5fbe7283b6</gtr:id><gtr:otherNames>Jovanovic I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>Ew4svnWtmvS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71881636-0522-46CE-ADE9-E7105B7F0364</gtr:id><gtr:title>Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b8ad9e217f3615bb43fcebd9d1028a0"><gtr:id>4b8ad9e217f3615bb43fcebd9d1028a0</gtr:id><gtr:otherNames>McHedlidze T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>pm_14176_26_23954132</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1DDFA49-7241-4E81-9F18-6CDAA08F96C3</gtr:id><gtr:title>Deciphering the transcriptional switches of innate lymphoid cell programming: the right factors at the right time.</gtr:title><gtr:parentPublicationTitle>Genes and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f61651130ee7c62d38b8dee3a8f60db2"><gtr:id>f61651130ee7c62d38b8dee3a8f60db2</gtr:id><gtr:otherNames>Lim AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1466-4879</gtr:issn><gtr:outcomeId>5675ded9e3963</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0F8C8DA-0FA6-44A2-B593-97CAE7BBD67D</gtr:id><gtr:title>Dysregulation of type 2 innate lymphoid cells and T2 cells impairs pollutant-induced allergic airway responses.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00266885569109098aa1bf645f3ee5ab"><gtr:id>00266885569109098aa1bf645f3ee5ab</gtr:id><gtr:otherNames>De Grove KC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>58b07846960d83.36881820</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29EAFF27-5A18-463D-9DB5-9C076CE32E43</gtr:id><gtr:title>The topography of mutational processes in breast cancer genomes.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1850dbb7e4d9b3526c6b48673d5bc82d"><gtr:id>1850dbb7e4d9b3526c6b48673d5bc82d</gtr:id><gtr:otherNames>Morganella S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58ac82d6195910.94408415</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1967446C-E546-4763-A9C2-9709864DE5D0</gtr:id><gtr:title>Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff570f150b0bd3d9469e8d6e9b096b31"><gtr:id>ff570f150b0bd3d9469e8d6e9b096b31</gtr:id><gtr:otherNames>Schulze J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0884-0431</gtr:issn><gtr:outcomeId>HvwCruEdwB2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3BBFBBB-FC96-49E4-A106-FF70C782EE9B</gtr:id><gtr:title>IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a403745fd970dd02e95d4f1364a9eed"><gtr:id>6a403745fd970dd02e95d4f1364a9eed</gtr:id><gtr:otherNames>Eller K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>abf3CbRvCEt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8069E71-0470-4194-983D-A41674F0E2D4</gtr:id><gtr:title>IL-33 Precedes IL-5 in Regulating Eosinophil Commitment and Is Required for Eosinophil Homeostasis.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47561d7b3f5228ac2b1bda2e757df4d6"><gtr:id>47561d7b3f5228ac2b1bda2e757df4d6</gtr:id><gtr:otherNames>Johnston LK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>58b0792ba6b870.62524892</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03D00BFE-7E50-4579-A48A-8F4CA2B19ACB</gtr:id><gtr:title>IL-25/IL-33-responsive TH2 cells characterize nasal polyps with a default TH17 signature in nasal mucosa.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9c387404eae083333cd6a2b3efaee3a"><gtr:id>a9c387404eae083333cd6a2b3efaee3a</gtr:id><gtr:otherNames>Lam EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>56c4b84a837500.58535173</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B4FFAB3-85A7-4511-877F-A4F5CDF9E9C3</gtr:id><gtr:title>IL-25 drives remodelling in allergic airways disease induced by house dust mite.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ee4d0adbf9f333954f131af5f3e0a83"><gtr:id>4ee4d0adbf9f333954f131af5f3e0a83</gtr:id><gtr:otherNames>Gregory LG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_14176_26_23093652</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65CBE5B6-F8E8-42F7-BBBA-BEC7AA2263E6</gtr:id><gtr:title>Modulation of ozone-induced airway hyperresponsiveness and inflammation by interleukin-13.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/586e7e456a80f6b95e7253d11875a3e0"><gtr:id>586e7e456a80f6b95e7253d11875a3e0</gtr:id><gtr:otherNames>Williams AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>9B3A5C05392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F911408-26B6-41B5-9ACA-885405D3EC2C</gtr:id><gtr:title>STAT3 Activation Impairs the Stability of Th9 Cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4d20f217976e473dd137adbc1afa571"><gtr:id>e4d20f217976e473dd137adbc1afa571</gtr:id><gtr:otherNames>Ulrich BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>58be741a911a26.06967404</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDBC22DE-18A3-4782-B084-2E921C096C37</gtr:id><gtr:title>IL-9 promotes IL-13-dependent paneth cell hyperplasia and up-regulation of innate immunity mediators in intestinal mucosa.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c432249f53404389baf38b1249697e36"><gtr:id>c432249f53404389baf38b1249697e36</gtr:id><gtr:otherNames>Steenwinckel V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>gRQW4VyehvP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6EA7A1B-E69B-4006-A282-8302AAE09F8F</gtr:id><gtr:title>Chitin activates parallel immune modules that direct distinct inflammatory responses via innate lymphoid type 2 and ?d T cells.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f32a245264911f1836fba3b2708931fc"><gtr:id>f32a245264911f1836fba3b2708931fc</gtr:id><gtr:otherNames>Van Dyken SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>545a5b5f7ad834.54117537</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00520CFF-28BD-438E-B04C-5E4CADA9F2C2</gtr:id><gtr:title>An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6f27721434332b4bc15c0a2d3692d4a"><gtr:id>c6f27721434332b4bc15c0a2d3692d4a</gtr:id><gtr:otherNames>Morita H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>56c4b849729fd0.48379149</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>845092C8-BF3B-4BAF-9EC8-0BF95C7B9A20</gtr:id><gtr:title>MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88f7632d46b6836b8594e227c55d3fc9"><gtr:id>88f7632d46b6836b8594e227c55d3fc9</gtr:id><gtr:otherNames>Oliphant CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>545a5b5e39c035.96360812</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>003D9BAD-387A-4A24-BAE2-773B17A53700</gtr:id><gtr:title>Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18f3d455973d0aabe68ed89b739a95be"><gtr:id>18f3d455973d0aabe68ed89b739a95be</gtr:id><gtr:otherNames>McSorley HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>545a5b60032f85.90379157</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9459B7C7-3A98-4F24-A584-FBEE9A3B9300</gtr:id><gtr:title>IL-9 regulates intestinal barrier function in experimental T cell-mediated colitis.</gtr:title><gtr:parentPublicationTitle>Tissue barriers</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9679509f4e1641a996540d3eb9cc6a30"><gtr:id>9679509f4e1641a996540d3eb9cc6a30</gtr:id><gtr:otherNames>Gerlach K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2168-8362</gtr:issn><gtr:outcomeId>56c4b84ab771b5.08545122</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76A4E382-59FD-4368-9686-5D8330C6EC07</gtr:id><gtr:title>IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfc426fe0d06111dd3a01914016493e7"><gtr:id>cfc426fe0d06111dd3a01914016493e7</gtr:id><gtr:otherNames>Hams E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>545a5b5e880239.03973886</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22C3DA4C-8B78-48C3-836D-D71CFB39F743</gtr:id><gtr:title>Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e225fcd06d8aceca5dfde99685bb18c"><gtr:id>4e225fcd06d8aceca5dfde99685bb18c</gtr:id><gtr:otherNames>Alves-Filho JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>hBRmPgFytdq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B94D18D9-D708-4712-8224-96CFA161EF1D</gtr:id><gtr:title>Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1083a4194641c753ca668be8ecd1eefb"><gtr:id>1083a4194641c753ca668be8ecd1eefb</gtr:id><gtr:otherNames>Ballantyne SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>B0EACDA422F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>874FAA7D-B1BE-4E22-AF29-D91AEC1FC13E</gtr:id><gtr:title>TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9679509f4e1641a996540d3eb9cc6a30"><gtr:id>9679509f4e1641a996540d3eb9cc6a30</gtr:id><gtr:otherNames>Gerlach K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>545a5b5ed579b1.77412555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DCC76BB-69BE-4C6C-8B0E-984EBEA12821</gtr:id><gtr:title>Single-cell analysis of CD4+ T-cell differentiation reveals three major cell states and progressive acceleration of proliferation.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6b5a13fd7b61c54fb4b0fc9f270bbc5"><gtr:id>d6b5a13fd7b61c54fb4b0fc9f270bbc5</gtr:id><gtr:otherNames>Proserpio V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>58b07846bd6ad3.62968300</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>337CD6AB-8FDE-491E-8046-116C23558629</gtr:id><gtr:title>A dominant role for the methyl-CpG-binding protein Mbd2 in controlling Th2 induction by dendritic cells.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/680d0666bb1fab7f3aa93e617ef2e38c"><gtr:id>680d0666bb1fab7f3aa93e617ef2e38c</gtr:id><gtr:otherNames>Cook PC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56c4b849417d27.41647916</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACF69DB4-06C1-4D8C-9F66-44843D401635</gtr:id><gtr:title>Tim-1 is induced on germinal centre B cells through B-cell receptor signalling but is not essential for the germinal centre response.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3af41585d570dd3045c7661eaf6dae62"><gtr:id>3af41585d570dd3045c7661eaf6dae62</gtr:id><gtr:otherNames>Wong SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>LLomKonHsXp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE3F2086-79AE-4361-97A7-C2D32359E84D</gtr:id><gtr:title>Innate lymphoid cells in the airways.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/191489dc6bbd83835665b20955d875a3"><gtr:id>191489dc6bbd83835665b20955d875a3</gtr:id><gtr:otherNames>Walker JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pm_14176_26_22678892</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECAEB97A-1AAF-4B3A-A8DE-180810466015</gtr:id><gtr:title>Mice lacking SIGNR1 have stronger T helper 1 responses to Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Microbes and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/592d4b4706b2788cfb99a2edf3e9d026"><gtr:id>592d4b4706b2788cfb99a2edf3e9d026</gtr:id><gtr:otherNames>Wieland CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1286-4579</gtr:issn><gtr:outcomeId>D059AC64C0A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2827BC15-6829-4BBC-BA80-3458EE42229A</gtr:id><gtr:title>ST2 deficient mice display a normal host defense against pulmonary infection with Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Microbes and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/592d4b4706b2788cfb99a2edf3e9d026"><gtr:id>592d4b4706b2788cfb99a2edf3e9d026</gtr:id><gtr:otherNames>Wieland CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1286-4579</gtr:issn><gtr:outcomeId>X1Z6pWL9ash</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E79A0ED7-F0D2-4822-9775-E2355E8636FA</gtr:id><gtr:title>Advances in the 5q- syndrome.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd7d6f4d0181606905b9598719d7034c"><gtr:id>fd7d6f4d0181606905b9598719d7034c</gtr:id><gtr:otherNames>Boultwood J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>qCzB7BwCrpt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>338160B1-8D50-4DDD-B6BE-D3D5F18CE062</gtr:id><gtr:title>Vaginal epithelial cell-derived S100 alarmins induced by Candida albicans via pattern recognition receptor interactions are sufficient but not necessary for the acute neutrophil response during experimental vaginal candidiasis.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4ceb4022f19c6c46748260beb67783e"><gtr:id>e4ceb4022f19c6c46748260beb67783e</gtr:id><gtr:otherNames>Yano J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>545a5b5e5c6d02.06229435</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D2E9FA0-E5B9-4D4F-BFFC-7E9946A54B4E</gtr:id><gtr:title>The IL-13/IL-4Ra axis is involved in tuberculosis-associated pathology.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6132c211db7e4bdbb64ca6902d76ac86"><gtr:id>6132c211db7e4bdbb64ca6902d76ac86</gtr:id><gtr:otherNames>Heitmann L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>545a5b5f2bcf41.07976008</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>667A888F-BA61-4772-8DA9-CCFFFD8730EF</gtr:id><gtr:title>Type-2 innate lymphoid cells control the development of atherosclerosis in mice.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff9dab4a6ebb50cf7ea6861389d7404e"><gtr:id>ff9dab4a6ebb50cf7ea6861389d7404e</gtr:id><gtr:otherNames>Newland SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a8d98376bcc61.99022773</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89DA9229-5050-4130-B947-F4C80F3699B9</gtr:id><gtr:title>Aberrant production of IL-13 by T cells promotes exocrinopathy in Id3 knockout mice.</gtr:title><gtr:parentPublicationTitle>Cytokine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16302b7c0e5215e3a157e56c267e41ee"><gtr:id>16302b7c0e5215e3a157e56c267e41ee</gtr:id><gtr:otherNames>Belle I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1043-4666</gtr:issn><gtr:outcomeId>545a5b5f077384.31076383</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D8AC1ED-8C5D-4D3B-8985-80DD769C52AC</gtr:id><gtr:title>IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63ff2ec91e39761c3b838f4287d94b6e"><gtr:id>63ff2ec91e39761c3b838f4287d94b6e</gtr:id><gtr:otherNames>Barlow JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>pm_14176_26_23810766</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01A36C00-B2DE-418B-9CB9-4F30684864EA</gtr:id><gtr:title>A Trypanosoma brucei kinesin heavy chain promotes parasite growth by triggering host arginase activity.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00915e786529853b3e799856fe68ab57"><gtr:id>00915e786529853b3e799856fe68ab57</gtr:id><gtr:otherNames>De Muylder G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>545a605ab384a4.63152425</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25329978-55B1-4B1D-B182-C55F4D33DA53</gtr:id><gtr:title>IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25cb245daba183dd2c9184b20106e2c7"><gtr:id>25cb245daba183dd2c9184b20106e2c7</gtr:id><gtr:otherNames>Espinassous Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>UUFmDTMrkiA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>749AA8E4-3244-4139-96B3-1B2349736198</gtr:id><gtr:title>Transcription factor RORa is critical for nuocyte development.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3af41585d570dd3045c7661eaf6dae62"><gtr:id>3af41585d570dd3045c7661eaf6dae62</gtr:id><gtr:otherNames>Wong SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>pm_14176_26_22267218</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24B9FA2A-58C0-4F31-9DE8-50EAB0ECB844</gtr:id><gtr:title>Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/062bd1c2e9a5ec214e9f1d986a7cedde"><gtr:id>062bd1c2e9a5ec214e9f1d986a7cedde</gtr:id><gtr:otherNames>He R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>kN5e9ck6UEb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BD9F2B0-1347-4E24-89D7-C21B7A2CF5C3</gtr:id><gtr:title>GRAF1a is a brain-specific protein that promotes lipid droplet clustering and growth, and is enriched at lipid droplet junctions.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a98f0786d0c511c5adf85e9463e96dc"><gtr:id>0a98f0786d0c511c5adf85e9463e96dc</gtr:id><gtr:otherNames>Lucken-Ardjomande H?sler S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>545a5b6026b9d6.00884982</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A2612B4-249D-47CD-AE9C-6F36B5D74986</gtr:id><gtr:title>ILC2s regulate adaptive Th2 cell functions via PD-L1 checkpoint control.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d6bf506583f087931cb96e19b534366"><gtr:id>4d6bf506583f087931cb96e19b534366</gtr:id><gtr:otherNames>Schwartz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>5a8d98382f8df7.88626717</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE0058A4-5678-4616-9342-B9DD254610AE</gtr:id><gtr:title>First-Breath-Induced Type 2 Pathways Shape the Lung Immune Environment.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5155fa605b57a79fe2d6f3b92d75aa97"><gtr:id>5155fa605b57a79fe2d6f3b92d75aa97</gtr:id><gtr:otherNames>Saluzzo S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58be73d069de58.97719185</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5504127B-AB90-4F31-B047-CE2DBCB37C24</gtr:id><gtr:title>Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2476c5e7ee94fae5cfa598d1851e21b"><gtr:id>b2476c5e7ee94fae5cfa598d1851e21b</gtr:id><gtr:otherNames>Smith P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>C2D70B49ABC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52AB02FC-82DB-418E-B224-E9A80B66DB75</gtr:id><gtr:title>Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0838d62f3242beb03753c3117dbcf25d"><gtr:id>0838d62f3242beb03753c3117dbcf25d</gtr:id><gtr:otherNames>Trabanelli S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a8d98387bd7d8.25554081</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EA9115A-A5EF-41E0-958C-377C94727249</gtr:id><gtr:title>Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebc4980131a1a3c04cdd651f1da8f04b"><gtr:id>ebc4980131a1a3c04cdd651f1da8f04b</gtr:id><gtr:otherNames>Chang YJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>eouJpFgcHEb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A73D3C03-DD59-43E0-8E84-AEC62F25E774</gtr:id><gtr:title>Harnessing mutation: The best of two worlds.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e78f2eaabec13daf7e953ba381ba796"><gtr:id>1e78f2eaabec13daf7e953ba381ba796</gtr:id><gtr:otherNames>Conticello SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>58ac823c01a2a5.62792648</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C6072A4-759B-4FE6-8E52-689C540FD61C</gtr:id><gtr:title>Innate lymphoid cells in inflammation and immunity.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bf96f4c18528646e7e73b54a3ef3073"><gtr:id>5bf96f4c18528646e7e73b54a3ef3073</gtr:id><gtr:otherNames>McKenzie ANJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>545a5b60497f13.32854856</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>296FCF26-E405-478A-AF32-1FFFC757834B</gtr:id><gtr:title>Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipase.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/491c3e1b512dfea6622f88c5f22471f8"><gtr:id>491c3e1b512dfea6622f88c5f22471f8</gtr:id><gtr:otherNames>Jarrett R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>58b43b4e703086.86995765</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF0E88E4-4D91-45AA-80D8-D2B641F9E201</gtr:id><gtr:title>IL-13 mediates in vivo IL-9 activities on lung epithelial cells but not on hematopoietic cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c432249f53404389baf38b1249697e36"><gtr:id>c432249f53404389baf38b1249697e36</gtr:id><gtr:otherNames>Steenwinckel V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>D30E5731129</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>298DDD06-4CB2-4167-9AAD-AF9D0F007833</gtr:id><gtr:title>The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.</gtr:title><gtr:parentPublicationTitle>mBio</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30e2a7ec1b76e87400bd095ffe5192a2"><gtr:id>30e2a7ec1b76e87400bd095ffe5192a2</gtr:id><gtr:otherNames>Rostan O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_14176_26_24045639</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C7DD7F6-2E04-4735-8D4D-DE7876DDEBE9</gtr:id><gtr:title>The C-type lectin SIGNR1 binds Schistosoma mansoni antigens in vitro, but SIGNR1-deficient mice have normal responses during schistosome infection.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f05f075d4358c2d78b4fd9bd1b68a270"><gtr:id>f05f075d4358c2d78b4fd9bd1b68a270</gtr:id><gtr:otherNames>Saunders SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>BdUspr85yBw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F539ECB-B00C-471D-94D3-5A2D1C66CBA6</gtr:id><gtr:title>Intrinsic transcriptional heterogeneity in B cells controls early class switching to IgE.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39bb6d92ef9da2390ac6bafe8e8bdfcf"><gtr:id>39bb6d92ef9da2390ac6bafe8e8bdfcf</gtr:id><gtr:otherNames>Wu YL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>58ac828b9bda26.83021388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A45274EF-8737-4AA0-A2E5-367FC576EB83</gtr:id><gtr:title>Reciprocal expression of IL-25 and IL-17A is important for allergic airways hyperreactivity.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63ff2ec91e39761c3b838f4287d94b6e"><gtr:id>63ff2ec91e39761c3b838f4287d94b6e</gtr:id><gtr:otherNames>Barlow JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>taqT1Mw9waE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE1F3D4C-98F1-4A0F-9317-AC9E695CD8C3</gtr:id><gtr:title>IL-33 exacerbates autoantibody-induced arthritis.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8d926f151e1a5ca9c91291369227789"><gtr:id>e8d926f151e1a5ca9c91291369227789</gtr:id><gtr:otherNames>Xu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>PWcCzwMUU3N</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC28BFF8-AFCA-4F2C-8CC4-B1E850B0EA22</gtr:id><gtr:title>Group 2 Innate Lymphoid Cells Express Functional NKp30 Receptor Inducing Type 2 Cytokine Production.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2abd7ea4a2d38b6996263dc56bf14550"><gtr:id>2abd7ea4a2d38b6996263dc56bf14550</gtr:id><gtr:otherNames>Salimi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>58b075e7075821.41654984</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9F0EE70-221F-405D-B4CC-00E301921FAB</gtr:id><gtr:title>Development and function of group 2 innate lymphoid cells.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/191489dc6bbd83835665b20955d875a3"><gtr:id>191489dc6bbd83835665b20955d875a3</gtr:id><gtr:otherNames>Walker JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn><gtr:outcomeId>pm_14176_26_23562755</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8970D303-03F4-49B8-A8ED-69327CA54AB9</gtr:id><gtr:title>Single-cell RNA sequencing reveals T helper cells synthesizing steroids de novo to contribute to immune homeostasis.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbeb7f3abb900b7f62cab77f20f48bbb"><gtr:id>fbeb7f3abb900b7f62cab77f20f48bbb</gtr:id><gtr:otherNames>Mahata B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545a5b5f9fa140.10126932</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19BCF775-1988-4162-A282-BE2A309072AE</gtr:id><gtr:title>Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6714ca3f31cf548af93bdf5596ab6226"><gtr:id>6714ca3f31cf548af93bdf5596ab6226</gtr:id><gtr:otherNames>Bruce DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>5a8d8c5e5c1ae5.72193559</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71C8AB18-C3D5-46CF-97BC-7D102B9B9A1D</gtr:id><gtr:title>Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09f10630401f3710ea7e1098f0af7c8d"><gtr:id>09f10630401f3710ea7e1098f0af7c8d</gtr:id><gtr:otherNames>Stier MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>58b07846185a81.20688661</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DD660F7-E324-4FCE-AF01-14D3F9D7E918</gtr:id><gtr:title>Epithelial cell-specific Act1 adaptor mediates interleukin-25-dependent helminth expulsion through expansion of Lin(-)c-Kit(+) innate cell population.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99441e24b8fcebfd6687bfd2657c5a61"><gtr:id>99441e24b8fcebfd6687bfd2657c5a61</gtr:id><gtr:otherNames>Kang Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>pm_14176_26_22608496</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69D3A959-8025-4F96-9684-1F99280A832B</gtr:id><gtr:title>Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b6ce39b7f477bffdf3ee1b97bcd2536"><gtr:id>8b6ce39b7f477bffdf3ee1b97bcd2536</gtr:id><gtr:otherNames>Halim TY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>56c4b84a12dd14.88711706</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>690E6D7B-B3C3-419A-8424-DEF0767CBAE3</gtr:id><gtr:title>TH9 cell generation. TH9: the latest addition to the expanding repertoire of IL-25 targets.</gtr:title><gtr:parentPublicationTitle>Immunology and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70a83ce11c46bd184c75e59dcc3d7fd5"><gtr:id>70a83ce11c46bd184c75e59dcc3d7fd5</gtr:id><gtr:otherNames>Neill DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0818-9641</gtr:issn><gtr:outcomeId>mubS1apPjfB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA23379E-A589-4612-AF1B-A0BC485B4C79</gtr:id><gtr:title>C-type lectin SIGN-R1 has a role in experimental colitis and responsiveness to lipopolysaccharide.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f05f075d4358c2d78b4fd9bd1b68a270"><gtr:id>f05f075d4358c2d78b4fd9bd1b68a270</gtr:id><gtr:otherNames>Saunders SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>GpTHEn14puy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA3C427A-15E2-4952-9440-4E5B92BFE92D</gtr:id><gtr:title>IL-25 as a potential therapeutic target in allergic asthma.</gtr:title><gtr:parentPublicationTitle>Immunotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/472afcd9cf4f5d2bee85deb9c81bc15d"><gtr:id>472afcd9cf4f5d2bee85deb9c81bc15d</gtr:id><gtr:otherNames>Knolle MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-743X</gtr:issn><gtr:outcomeId>56c4b84a53a0e0.74552152</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>392DE2A0-C5C2-43E9-856F-9D65467C6071</gtr:id><gtr:title>Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13.</gtr:title><gtr:parentPublicationTitle>Journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/353487ba14f28e9774c8dd6287db2f14"><gtr:id>353487ba14f28e9774c8dd6287db2f14</gtr:id><gtr:otherNames>Camelo A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0944-1174</gtr:issn><gtr:outcomeId>pm_14176_26_22539101</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>810E3D0B-93DD-4DBE-9B34-90BD0386A057</gtr:id><gtr:title>Complete inhibition of allergic airway inflammation and remodelling in quadruple IL-4/5/9/13-/- mice.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/728898d4a3b392837ce5cb8b1d8fb6ff"><gtr:id>728898d4a3b392837ce5cb8b1d8fb6ff</gtr:id><gtr:otherNames>Nath P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>27B78BDB8B6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A39D8EBC-86F6-4415-BA99-6C8CDB309325</gtr:id><gtr:title>IL-33 is a chemoattractant for human Th2 cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63e638ecaaad0ff3875bc715972a1fc2"><gtr:id>63e638ecaaad0ff3875bc715972a1fc2</gtr:id><gtr:otherNames>Komai-Koma M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>2104B0FC214</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87A93B53-2F76-4C15-932A-E56528D9FAEC</gtr:id><gtr:title>The ST2 pathway is involved in acute pancreatitis: a translational study in humans and mice.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d3d1fd7a99ec7ed9ed529318b4ab2bf"><gtr:id>3d3d1fd7a99ec7ed9ed529318b4ab2bf</gtr:id><gtr:otherNames>Ouziel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>pm_14176_26_22542450</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D4B01BC-1695-44D7-ACAF-D48D2A298CFF</gtr:id><gtr:title>Group 2 innate lymphoid cells in disease.</gtr:title><gtr:parentPublicationTitle>International immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b6ce39b7f477bffdf3ee1b97bcd2536"><gtr:id>8b6ce39b7f477bffdf3ee1b97bcd2536</gtr:id><gtr:otherNames>Halim TY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0953-8178</gtr:issn><gtr:outcomeId>56c4b849d97bf8.03055447</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A248150-406D-4316-8530-2EF65AFE96E0</gtr:id><gtr:title>A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2abd7ea4a2d38b6996263dc56bf14550"><gtr:id>2abd7ea4a2d38b6996263dc56bf14550</gtr:id><gtr:otherNames>Salimi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>545a605a5c2b25.21212641</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>509FC3EE-DE1F-4A6A-AE2E-F608F6E7F4B8</gtr:id><gtr:title>IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c46e2ecdbdcf081c5e7884ac05702bb5"><gtr:id>c46e2ecdbdcf081c5e7884ac05702bb5</gtr:id><gtr:otherNames>Kurowska-Stolarska M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>936201480F6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4320372A-6A0F-49E4-B127-3112DF4C1FB0</gtr:id><gtr:title>IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e1930c9db358c717fa9c55f59f2a171"><gtr:id>8e1930c9db358c717fa9c55f59f2a171</gtr:id><gtr:otherNames>Hardman CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pm_14176_26_23169007</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B01C5F3-3C72-49B6-95D8-0CA08870D07C</gtr:id><gtr:title>Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/972bcd649809975a6ae6579df5d505cb"><gtr:id>972bcd649809975a6ae6579df5d505cb</gtr:id><gtr:otherNames>Xue L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>54491433d52e59.46754698</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>520A261A-D475-4F8B-9301-21B576DC16D3</gtr:id><gtr:title>Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/750066e51c98a8fdb0c4329e5529b17d"><gtr:id>750066e51c98a8fdb0c4329e5529b17d</gtr:id><gtr:otherNames>Luzina IG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_14176_26_22634619</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6208A9E0-177C-4B17-B659-33D5E7950FEF</gtr:id><gtr:title>Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71ebe0458d5dbd715a6c20159d26688f"><gtr:id>71ebe0458d5dbd715a6c20159d26688f</gtr:id><gtr:otherNames>Rauber S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>5a8d9837cea747.44101551</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38B243B0-1EB3-42C5-BE90-817DB4892254</gtr:id><gtr:title>IL-4-producing ILC2s are required for the differentiation of T2 cells following Heligmosomoides polygyrus infection.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f5d2641d8a1b6103fcdfa7ae980dc3c"><gtr:id>3f5d2641d8a1b6103fcdfa7ae980dc3c</gtr:id><gtr:otherNames>Pelly VS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>58b079509b7507.55933092</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43100EF7-777A-439D-9FD5-5567DB43401D</gtr:id><gtr:title>Tim1 and Tim3 are not essential for experimental allergic asthma.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63ff2ec91e39761c3b838f4287d94b6e"><gtr:id>63ff2ec91e39761c3b838f4287d94b6e</gtr:id><gtr:otherNames>Barlow JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>M42h21B97eN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A3950A0-3EE3-49CD-A20A-1B475C65516A</gtr:id><gtr:title>IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72fe9cad10182fb77c72000b44933ab2"><gtr:id>72fe9cad10182fb77c72000b44933ab2</gtr:id><gtr:otherNames>Bartemes KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_14176_26_22198948</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFF9E59F-38DF-4E2D-9FC0-0D2608298F22</gtr:id><gtr:title>The IL-4/IL-13/Stat6 signalling pathway promotes luminal mammary epithelial cell development.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f6a7bb4c254e5bd21e4f94278d975c39"><gtr:id>f6a7bb4c254e5bd21e4f94278d975c39</gtr:id><gtr:otherNames>Khaled WT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>1F63564E117</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D9EC733-30D2-4959-AFB2-EE7007556FB7</gtr:id><gtr:title>IFN-? increases susceptibility to influenza A infection through suppression of group II innate lymphoid cells.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5eda9d9bb90dac75bbba0537bd44098e"><gtr:id>5eda9d9bb90dac75bbba0537bd44098e</gtr:id><gtr:otherNames>Califano D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>5a8d975dd72920.88834506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B46FE499-3D3A-4F1E-948F-80EBD3BDC0D1</gtr:id><gtr:title>Type-2 innate lymphoid cells in asthma and allergy.</gtr:title><gtr:parentPublicationTitle>Annals of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99de1b8b9bbe378d8a1be19206b60225"><gtr:id>99de1b8b9bbe378d8a1be19206b60225</gtr:id><gtr:otherNames>McKenzie AN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2325-6621</gtr:issn><gtr:outcomeId>56c4b84bd85382.74792753</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90FAAFB9-ACE6-449A-9EE2-17FAAD9C5BCA</gtr:id><gtr:title>Pulmonary suppressor of cytokine signaling-1 induced by IL-13 regulates allergic asthma phenotype.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44023b588cd22b7b119c32a5f522eb19"><gtr:id>44023b588cd22b7b119c32a5f522eb19</gtr:id><gtr:otherNames>Fukuyama S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>mgcLKrNvzfV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA42C1AE-0CA3-4199-ABBE-A046695C070F</gtr:id><gtr:title>New kids on the block: group 2 innate lymphoid cells and type 2 inflammation in the lung.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dca5e443c5ceacc605d4b90b2d3db4b4"><gtr:id>dca5e443c5ceacc605d4b90b2d3db4b4</gtr:id><gtr:otherNames>Halim TYF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>545a5b60760404.02289850</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92D0C339-A6F5-4330-8FC2-74F0021BEC3B</gtr:id><gtr:title>CD1a presentation of endogenous antigens by group 2 innate lymphoid cells.</gtr:title><gtr:parentPublicationTitle>Science immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e1930c9db358c717fa9c55f59f2a171"><gtr:id>8e1930c9db358c717fa9c55f59f2a171</gtr:id><gtr:otherNames>Hardman CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2470-9468</gtr:issn><gtr:outcomeId>5a8da3242cfda3.84136262</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F94B9F20-0C3C-4BC7-BB1A-8BB7AA88CE26</gtr:id><gtr:title>Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/295172cf06eb3e4362654ec26ea2b873"><gtr:id>295172cf06eb3e4362654ec26ea2b873</gtr:id><gtr:otherNames>Fallon PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>EA45FFE9911</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F91127A-1456-414F-A6AC-297CE1B81158</gtr:id><gtr:title>Nuocytes: expanding the innate cell repertoire in type-2 immunity.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63ff2ec91e39761c3b838f4287d94b6e"><gtr:id>63ff2ec91e39761c3b838f4287d94b6e</gtr:id><gtr:otherNames>Barlow JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn><gtr:outcomeId>mD6naE76AuH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AF7C115-690C-45C9-8F58-EA0BC9B579C4</gtr:id><gtr:title>Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70a83ce11c46bd184c75e59dcc3d7fd5"><gtr:id>70a83ce11c46bd184c75e59dcc3d7fd5</gtr:id><gtr:otherNames>Neill DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>fjhd6G4xr36</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACDEF887-290A-49F7-80F7-0CA16D282348</gtr:id><gtr:title>Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host disease.</gtr:title><gtr:parentPublicationTitle>Experimental hematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74633c425eabf0362dfbc618747969bb"><gtr:id>74633c425eabf0362dfbc618747969bb</gtr:id><gtr:otherNames>Tawara I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0301-472X</gtr:issn><gtr:outcomeId>A94597740FB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>961B16C4-2691-43C3-9495-BC290142D6F7</gtr:id><gtr:title>TIM-3 is not essential for development of airway inflammation induced by house dust mite antigens.</gtr:title><gtr:parentPublicationTitle>Allergology international : official journal of the Japanese Society of Allergology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/273f1ae86eb2d3fbb376e7f0c8f1cfde"><gtr:id>273f1ae86eb2d3fbb376e7f0c8f1cfde</gtr:id><gtr:otherNames>Hiraishi Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1323-8930</gtr:issn><gtr:outcomeId>58b07845852e55.40144560</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B2E7E29-5309-4AEE-A268-DFFC6393A146</gtr:id><gtr:title>Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfc426fe0d06111dd3a01914016493e7"><gtr:id>cfc426fe0d06111dd3a01914016493e7</gtr:id><gtr:otherNames>Hams E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>545a605a8b3728.39442114</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04D101F7-1C47-4C67-81CD-A802FEA2F496</gtr:id><gtr:title>IL-33 promotes food anaphylaxis in epicutaneously sensitized mice by targeting mast cells.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5944792301f37fe3b4562802fac29b1"><gtr:id>f5944792301f37fe3b4562802fac29b1</gtr:id><gtr:otherNames>Galand C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>58b07845cea577.66045064</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>362EBAC2-9283-45FB-B967-2D0272D0499F</gtr:id><gtr:title>Nuocyte development and function are critical for type-2 immunity</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b98548a5c2acbca91b0212cf8d6c7dfe"><gtr:id>b98548a5c2acbca91b0212cf8d6c7dfe</gtr:id><gtr:otherNames>Barlow J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>56c7271d17b863.95522752</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE1AD624-CD01-4AD5-859C-88D634BA84BA</gtr:id><gtr:title>Type 2 innate lymphoid cells: new players in asthma and allergy.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4694996772177047ce1903b2332f9290"><gtr:id>4694996772177047ce1903b2332f9290</gtr:id><gtr:otherNames>Scanlon ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn><gtr:outcomeId>pm_14176_26_22985480</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>897BF704-8C51-470A-BA78-8245108B8B36</gtr:id><gtr:title>Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7e1acf9bed7bb2f288917c4a0c6e383"><gtr:id>f7e1acf9bed7bb2f288917c4a0c6e383</gtr:id><gtr:otherNames>Kim HY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>pm_14176_26_22119406</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C3B090E-F5E4-4CC3-A201-AB1C5FCD6CCA</gtr:id><gtr:title>Insights into the initiation of type 2 immune responses.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88f7632d46b6836b8594e227c55d3fc9"><gtr:id>88f7632d46b6836b8594e227c55d3fc9</gtr:id><gtr:otherNames>Oliphant CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>syTD79yGn59</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6253B0D-CE87-49BA-AAB9-D4DD9ACC3CD4</gtr:id><gtr:title>Helminth-modified pulmonary immune response protects mice from allergen-induced airway hyperresponsiveness.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e587c96dfcc954d413c5181c5c79835"><gtr:id>0e587c96dfcc954d413c5181c5c79835</gtr:id><gtr:otherNames>Mangan NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>EC92851882B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3274996B-C63B-473D-8EFD-F393B627F50B</gtr:id><gtr:title>Single-cell RNA-seq identifies a PD-1ILC progenitor and defines its development pathway.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33f8b5eefa1739d60bdb71d6a13794da"><gtr:id>33f8b5eefa1739d60bdb71d6a13794da</gtr:id><gtr:otherNames>Yu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>58b07845ab41d3.57725056</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>435609B7-B04B-4FA8-B85D-7146A4CDB620</gtr:id><gtr:title>Full-length IL-33 acts differently from mature IL-33 in vivo partially in an ST2-independent fashion</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c836a49cafe6d366ed755d446a442998"><gtr:id>c836a49cafe6d366ed755d446a442998</gtr:id><gtr:otherNames>Atamas S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>00221767</gtr:issn><gtr:outcomeId>56c7156f17c8a0.21876049</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D58C238F-56CD-429C-B453-C347B9AD7549</gtr:id><gtr:title>IL-33 activates B1 cells and exacerbates contact sensitivity.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63e638ecaaad0ff3875bc715972a1fc2"><gtr:id>63e638ecaaad0ff3875bc715972a1fc2</gtr:id><gtr:otherNames>Komai-Koma M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>Fv6XRhWUNky</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A6B8987-D856-469B-B733-35D6DCBCE631</gtr:id><gtr:title>Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a60e28f2a1214b4efd1d55a151a8fffd"><gtr:id>a60e28f2a1214b4efd1d55a151a8fffd</gtr:id><gtr:otherNames>Beale J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>56c7359f612597.70488976</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E59BA956-C698-483F-8E0E-E08AD75087F0</gtr:id><gtr:title>Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61065f6d3f532512e7013831a33187e8"><gtr:id>61065f6d3f532512e7013831a33187e8</gtr:id><gtr:otherNames>Pellagatti A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>bgCn1tGyhEo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87D8BF0A-C927-46DE-86AE-6D1D374A7605</gtr:id><gtr:title>Direct control of hepatic glucose production by interleukin-13 in mice.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74b78ff83c73fc5171311a101c3244ca"><gtr:id>74b78ff83c73fc5171311a101c3244ca</gtr:id><gtr:otherNames>Stanya KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>pm_14176_26_23257358</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DED5B9CC-F085-4293-B8F2-F691FA228D0A</gtr:id><gtr:title>Innate lymphoid cells--how did we miss them?</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/191489dc6bbd83835665b20955d875a3"><gtr:id>191489dc6bbd83835665b20955d875a3</gtr:id><gtr:otherNames>Walker JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>pm_14176_26_23292121</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8490ADE1-4F06-4216-8FB0-A26B2670E142</gtr:id><gtr:title>IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e52df1e2f9c54e4ee99081673b9e6d48"><gtr:id>e52df1e2f9c54e4ee99081673b9e6d48</gtr:id><gtr:otherNames>Jones LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>fsHWSYLj5fW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9F0D4BC-18A0-4C39-9581-B756B3B7A735</gtr:id><gtr:title>Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52d8fccd47711cf969124a13d0eb6e97"><gtr:id>52d8fccd47711cf969124a13d0eb6e97</gtr:id><gtr:otherNames>Takayama G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>91D723457AA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13F8BE4C-AC34-44E4-BF43-303CBE332F3F</gtr:id><gtr:title>The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4d69e3bf66746f86f43639f3a7efccb"><gtr:id>f4d69e3bf66746f86f43639f3a7efccb</gtr:id><gtr:otherNames>Rankin LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>pm_14176_26_23455676</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105178805</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>